Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7688603054340412,-2.240986640732235,0.0,0.0,0.0,21/29,17.12%,GRID2;GRIK2;GRIA4;GABRG3;GRIK1;GABRB3;GRIA2;GABRB1;GABRA3;GABRA2;GRIK4;GABRB2;GLRA3;GABRG2;GRID1;GABRA4;GABRG1;GLRA2;GRIK3;GABRA5;GABRE
prerank,ligand-gated ion channel activity (GO:0015276),-0.7284737367964421,-2.192655405050706,0.0,0.0,0.0,13/30,9.49%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,glutamate receptor activity (GO:0008066),-0.8386096467530986,-2.1811507644880224,0.0,0.0,0.0,13/19,9.49%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIA1;GRIA2;GRM8;GRIK4;GRM1;GRID1
prerank,ligand-gated channel activity (GO:0022834),-0.731817702234252,-2.1804530241186306,0.0,0.0,0.0,13/29,9.49%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,retinoid binding (GO:0005501),0.8833131322194976,2.17547374975812,0.0,0.0,0.0,9/22,7.53%,PTGDS;ALDH1A2;ABCA4;RBP1;CRABP2;NR2F2;CYP26B1;CRABP1;RBP4
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.8335678789319421,-2.1351841254602495,0.0,0.0,0.0,11/16,8.75%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.8335678789319421,-2.1351841254602495,0.0,0.0,0.0,11/16,8.75%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,cell adhesion mediator activity (GO:0098631),-0.76239825147681,-2.1302592179394986,0.0,0.0002835803436284814,0.002,12/24,9.64%,LRRC4C;BSG;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;CNTN6;BCAM;ROBO4;EMB;CD47
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.8297034068659991,-2.1297300230433014,0.0,0.00024813280067492125,0.002,11/17,7.11%,GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;GRIK4;GRIN3A;GRIN2A
prerank,anion channel activity (GO:0005253),-0.6064136229613383,-2.046632579467004,0.0,0.0007719687132108661,0.007,34/61,22.02%,SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;LRRC8C;GABRB1;GABRA3;LRRC8D;GLRB;GABRA2;ANO3;GABRB2;GLRA3;LRRC8B;SLC1A4;GLRA1;VDAC1;GABRG2;GABRA4;GABRG1;GLRA2;ANO5;ANO2;CLCN3;GABRA5;GABRE;GPR89A;GPR89B;CFTR;GABRA1;BEST1;VDAC3
prerank,ligand-gated anion channel activity (GO:0099095),-0.7887465460939462,-2.023009295642868,0.0,0.0010917843229696533,0.009,17/17,21.22%,GABRG3;GABRB3;GABRB1;GABRA3;GLRB;GABRA2;GABRB2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE;CFTR;GABRA1
prerank,chloride channel activity (GO:0005254),-0.5845698343330016,-2.000542094980176,0.0,0.0015339118587176948,0.015,31/59,21.27%,SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;GABRA2;ANO3;GABRB2;GLRA3;SLC1A4;GLRA1;GABRG2;GABRA4;GABRG1;TTYH2;GLRA2;CLCN1;TTYH1;ANO5;ANO2;CLCN3;GABRA5;GABRE;CLCN6;CFTR;GABRA1;BEST1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.7505933509598275,-1.9726389477821362,0.0,0.0019023514718410626,0.021,14/19,17.12%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;GABRA5;GABRE
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.670424547684259,-1.9562056358263762,0.0,0.0029012450540452325,0.033,15/28,17.12%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;CHRNA7;GABRA5;GABRE
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.6091211614567424,-1.922018276666396,0.0,0.005175341271219785,0.06,15/42,9.64%,STXBP6;LRRC4C;BSG;CD200;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;ANXA1;CNTN6;ROBO4;EMB;PDLIM1;CD47
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.793255511171684,-1.9003761683856057,0.0,0.006418368444124629,0.081,12/13,17.12%,GABRG3;GABRA3;GLRB;GABRA2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE
prerank,GABA receptor activity (GO:0016917),-0.7083372900105961,-1.893794661771956,0.0,0.006699585618222873,0.089,13/21,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GPR156;GABBR2;GABRA4;GABRG1;GABRA5;GABRE
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8230310281098758,1.8463337095659227,0.0018656716417910447,0.23219032852115343,0.333,7/15,8.15%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH3B1;ALDH2;ALDH1L1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8822944402932614,1.8404392850101712,0.0,0.17422650913564186,0.366,4/10,5.11%,SLC6A13;SLC6A1;SLC6A12;SLC10A4
prerank,GABA-A receptor activity (GO:0004890),-0.7207876426845625,-1.8334133816848348,0.002232142857142857,0.01909162960487041,0.251,11/18,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.7941275859826631,-1.8139573483106208,0.0,0.02348990513055921,0.311,11/12,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.6071049332739157,-1.8139557235351709,0.0,0.022253594334213988,0.311,12/31,16.01%,SLC12A7;HCN1;ABCC9;KCNK5;SLC12A2;KCNK9;SLC12A8;SLC12A4;KCNK1;SLC12A6;TMEM38A;SLC12A5
prerank,store-operated calcium channel activity (GO:0015279),-0.793220947176287,-1.8094153262881074,0.002127659574468085,0.0226793379816878,0.329,7/10,15.04%,STIM2;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6238159932405057,1.808184672246003,0.001579778830963665,0.22012849327330133,0.524,12/55,5.93%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A4;SLC38A3;SLC7A2;PDPN;SLC16A13;SLC19A1
prerank,cAMP binding (GO:0030552),-0.7901012732715122,-1.807944467903959,0.0021645021645021645,0.022024740021812057,0.333,5/11,2.10%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1
prerank,glutamate receptor binding (GO:0035254),-0.7082070600373915,-1.804672965819841,0.0045045045045045045,0.02183568645939307,0.34,10/17,13.89%,HIP1;SHANK3;GNAS;IGSF11;SYNDIG1;SHISA6;NSF;SHANK2;HOMER1;SHANK1
prerank,AMP binding (GO:0016208),0.8426034390238986,1.779932956189715,0.0019723865877712033,0.2744067518886359,0.674,3/11,2.80%,PRKAG2;MPPED2;PRKAG3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.8401416628486452,1.7775732456608337,0.007272727272727273,0.2368810422286515,0.682,1/11,0.03%,PPP1R1A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.74055987252896,-1.7631058878971768,0.006198347107438017,0.03724149686651426,0.505,9/12,15.66%,PDE4D;PDE4B;PDE3A;PDE8A;PDE3B;PDE7B;PDE2A;PDE8B;PDE4C
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.6950797553620811,1.74920139758593,0.0034662045060658577,0.29077638543929235,0.796,6/26,1.42%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A12;SLC16A11
prerank,semaphorin receptor binding (GO:0030215),-0.636982729239227,-1.7475244281961861,0.0044943820224719105,0.04367137291878613,0.587,11/23,14.99%,SEMA3C;SEMA6A;SEMA6D;RIT2;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,cadherin binding (GO:0045296),-0.4043798929128191,-1.7370771373811271,0.0,0.04704597900796506,0.636,110/315,17.56%,STXBP6;CDH11;COBLL1;CTNND2;DOCK9;SPTBN1;CTNNA2;PTPRB;PTPRM;FMNL2;PTPRJ;AHNAK;MRTFB;CDH8;CDH2;CDH13;ITGA6;BSG;ANK3;MYO1B;BMPR2;CTNNA3;FNBP1L;ESYT2;RTN4;NOTCH3;LRRFIP1;PTPRT;IQGAP1;PROM1;FXYD5;CLINT1;CDH10;CDH12;F11R;EHD4;MYH9;YWHAE;EPN2;HSP90AB1;SHTN1;KDR;TRPC4;ANXA1;OLA1;DAB2IP;YWHAB;LIMA1;CDH6;FLNA;SH3GLB1;HSPA8;PSEN1;ITGB1;CDH20;CDH19;CDH7;CD2AP;TAGLN2;RPL14;BZW1;BZW2;HSPA5;RPL34;RDX;ANLN;PDLIM1;ABI1;RPL7A;RPS2;EFHD2;RPL23A;PCBP1;CALD1;MB21D2;RPL29;ERC1;MARK2;HNRNPK;CDH1;PAICS;AHSA1;CTNNB1;RANBP1;TNKS1BP1;RPL6;TES;ARGLU1;GAPVD1;ACVR1;GCN1;TMPO;CDK5R1;NCK1;RPS26;ALDOA;CCT8;CDH9;CBL;PKM;SEPTIN9;USP8;CAPZA1;APC;WASF2;PRDX1;SCRIB;PPP1CA;EMD;SCYL1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.80399263704483,1.7330747862147629,0.0038022813688212928,0.3180052605449347,0.874,6/13,8.15%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH2;ALDH1L1
prerank,diacylglycerol kinase activity (GO:0004143),-0.727535540083506,-1.7294834825234557,0.007858546168958742,0.04909212025660749,0.66,6/11,13.00%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,CoA-ligase activity (GO:0016405),0.7567435573550888,1.708896082847753,0.021359223300970873,0.3774907697938906,0.938,3/14,4.32%,ACSL1;ACSS3;ACSBG2
prerank,histone demethylase activity (GO:0032452),0.6683970184496288,1.703050897306247,0.009630818619582664,0.3591411445047971,0.947,14/27,21.00%,KDM7A;JARID2;FBXL19;KDM2B;KDM2A;JMJD6;HR;RIOX2;KDM3B;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,pentosyltransferase activity (GO:0016763),0.6309471377624639,1.7029585310844968,0.009868421052631578,0.3267660821690849,0.948,19/36,14.45%,LACC1;LARGE1;ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;LARGE2;SIRT4;ART4;QPRT
prerank,frizzled binding (GO:0005109),0.6490869815787161,1.6978349418451353,0.006688963210702341,0.31511544585013684,0.951,4/34,1.96%,WNT5B;RNF43;WNT4;WNT6
prerank,amyloid-beta binding (GO:0001540),-0.47677921978329946,-1.6959154852419391,0.0,0.06962422584863714,0.804,21/79,7.96%,NLGN1;APBB2;GRIA4;COL25A1;GRIN2B;CST3;GRIA1;GRIA2;TGFB2;GRIA3;APBA2;FZD4;APOE;GSAP;ITM2A;LDLR;GRIN2A;CACNA1B;HSPG2;SORL1;EPHB2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.7751841618374158,-1.6780886089069338,0.00816326530612245,0.08074950284821007,0.847,9/10,21.22%,GABRG3;GABRA3;GABRA2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6441132693563575,-1.6586314468935541,0.01072961373390558,0.09572792323969029,0.9,10/17,14.29%,ATP10A;ATP8B1;PITPNC1;PLTP;ABCG1;PITPNB;MTTP;PITPNA;ATP8B2;ABCB4
prerank,chemorepellent activity (GO:0045499),-0.595135997362101,-1.6484100673142446,0.0024390243902439024,0.10236305137176084,0.925,11/25,12.46%,NRG3;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;EPHA7;SEMA4D;SEMA3D;SEMA3G
prerank,amino acid:sodium symporter activity (GO:0005283),0.7726434537343401,1.6461349217022596,0.017408123791102514,0.4987878152813723,0.994,5/11,8.27%,SLC6A13;SLC6A1;SLC6A12;SLC38A1;SLC1A3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.7344692723983413,1.639832223365505,0.01855287569573284,0.49116080315807387,0.995,9/15,19.69%,KMT2A;CXXC1;ASH2L;KMT2C;WDR82;KMT2D;SETD1B;SETD3;SETD1A
prerank,voltage-gated sodium channel activity (GO:0005248),-0.6027402678047732,-1.6364036791359189,0.01932367149758454,0.11145164892250332,0.947,10/22,16.27%,HCN1;SCN1A;SCN2A;CACNA1G;SCN7A;SCN3A;SCN9A;SCN8A;CACNA1H;SCN2B
prerank,fatty acid synthase activity (GO:0004312),-0.7209483656279605,-1.6363486669915315,0.008492569002123142,0.10799980149375947,0.948,3/10,10.29%,ELOVL7;ELOVL5;ELOVL6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.6532147365724691,1.6347152925569242,0.022569444444444444,0.48140124678094276,0.996,15/25,13.19%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;SIRT4;ART4
prerank,histone acetyltransferase binding (GO:0035035),0.6827668453289631,1.6148897473195714,0.018867924528301886,0.5415261449816945,0.999,6/21,7.92%,EPAS1;KANSL1L;GLI3;TP53;BCAS3;MEF2A
prerank,lysine-acetylated histone binding (GO:0070577),0.678009971093401,1.6146822732680381,0.023172905525846704,0.4823058844245316,0.999,7/20,12.50%,ZMYND8;KMT2A;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,acetylation-dependent protein binding (GO:0140033),0.678009971093401,1.6146822732680381,0.023172905525846704,0.4823058844245316,0.999,7/20,12.50%,ZMYND8;KMT2A;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,sulfotransferase activity (GO:0008146),0.6160523021894778,1.614376435024479,0.01485148514851485,0.4577149059842833,0.999,5/33,3.34%,HS3ST3A1;UST;CHST15;CHST11;HS2ST1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7272826739497742,-1.608894606418158,0.022267206477732792,0.13531508730139039,0.975,7/10,13.89%,SHANK3;GNAS;IGSF11;SHISA6;NSF;SHANK2;SHANK1
prerank,BMP binding (GO:0036122),-0.7084036979628779,-1.605330813873747,0.015873015873015872,0.1351302040381424,0.976,3/11,1.86%,GREM2;BMPR2;ENG
prerank,sodium channel activity (GO:0005272),-0.521229779334746,-1.5914569387910606,0.013888888888888888,0.14930505092039545,0.986,14/37,15.43%,GRIK2;HCN1;GRIK1;SCN1A;SCN2A;GRIK4;CACNA1G;SCN7A;SCN3A;SCN9A;KCNK1;SCN8A;CACNA1H;GRIK3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.745780885049859,1.5793028681713999,0.04271844660194175,0.5855015859894886,1.0,1/10,0.04%,PRKAG2
prerank,amino acid binding (GO:0016597),-0.5267271060524621,-1.5749657409105164,0.0234375,0.1680410466792939,0.995,10/31,15.27%,GRM7;NOS3;GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;NOS1;GLRA2;GRIN1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6342919579054364,1.562282790701482,0.03595890410958904,0.6363575381753732,1.0,1/26,0.03%,PPP1R1A
prerank,sodium:proton antiporter activity (GO:0015385),-0.6851696804799022,-1.559941321862631,0.028629856850715747,0.18536190839607627,0.997,4/11,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,active ion transmembrane transporter activity (GO:0022853),0.5833983743879483,1.5556153724847328,0.028391167192429023,0.6404194873831185,1.0,3/37,1.25%,SLC22A6;SLC22A8;ATP13A3
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6277227835545586,1.5500762138827275,0.048598130841121495,0.6382721151988417,1.0,3/21,3.11%,FGF1;KL;FRS2
prerank,acid-thiol ligase activity (GO:0016878),0.698447151717497,1.5477333475271704,0.049079754601226995,0.6218127358502102,1.0,2/13,3.76%,ACSL1;ACSS3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.4542273884640486,-1.541356919446198,0.011560693641618497,0.21054721118321476,0.998,19/60,9.84%,NRP1;TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;NRP2;EPHA6;TIE1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;FLT4;ERBB2
prerank,glycine binding (GO:0016594),-0.6559923355951786,-1.5319767476572161,0.04925053533190578,0.21978203760293535,0.998,7/11,15.27%,GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;GLRA2;GRIN1
prerank,phospholipase C activity (GO:0004629),-0.5452926859173599,-1.526878935331631,0.0364963503649635,0.22326989404729414,0.998,8/25,9.32%,PLCB4;EDNRA;PLCL1;PLCE1;CHRM3;PLCG2;PDIA3;PLCH1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.6358838597582236,1.52466275401756,0.05338078291814947,0.7046122090620285,1.0,4/20,4.24%,LPGAT1;AGPAT4;MOGAT3;GPAT2
prerank,cyclic nucleotide binding (GO:0030551),-0.5569630172715607,-1.5224165027199021,0.027842227378190254,0.2265391949966744,0.998,6/21,2.15%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1;PDE11A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6042013586702328,-1.5183275973448584,0.04328018223234624,0.22863665205046316,1.0,8/15,15.38%,SLC1A5;SLC1A2;SLC1A1;SLC25A13;SLC1A4;SLC17A6;SLC38A7;SLC1A6
prerank,retinoic acid binding (GO:0001972),0.6879512464554409,1.5168099724802078,0.0779467680608365,0.7155142524591255,1.0,2/12,4.66%,NR2F2;CYP26B1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7428889602294396,1.5140926266379415,0.060362173038229376,0.7015967502500654,1.0,4/10,11.82%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6116514974506688,1.5135384139194508,0.054770318021201414,0.679303894033053,1.0,3/27,1.22%,SLC22A6;SLC22A8;SLC5A5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.6445270605553199,-1.5101601824755027,0.03991596638655462,0.23760735350210596,1.0,4/13,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,alkali metal ion binding (GO:0031420),0.6743909908540737,1.5064407024155522,0.06476190476190476,0.6894655941099843,1.0,4/13,12.69%,ATP1A2;ATP4A;HDAC4;TDG
prerank,peptidase inhibitor activity (GO:0030414),0.5541953111072093,1.4971398251156232,0.04723127035830619,0.7085323055175804,1.0,6/33,8.46%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG
prerank,NAD binding (GO:0051287),0.5969244205224246,1.4921850820438536,0.05641025641025641,0.7079843350452989,1.0,10/26,9.50%,SORD;ALDH1A1;CRYL1;SIRT5;BDH2;ALDH2;SIRT3;PARP9;SIRT1;ZC3HAV1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6490109847375269,-1.4918180439654583,0.03171247357293869,0.26678787578020846,1.0,4/12,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5808315672771046,1.4902889395135845,0.05299145299145299,0.6939952811615753,1.0,5/27,6.34%,SLC41A1;ITPR2;ITPR1;CNNM2;MRS2
prerank,R-SMAD binding (GO:0070412),0.636328418773371,1.488255323219735,0.0748663101604278,0.6826815995204791,1.0,5/18,6.17%,SMAD3;DDX5;PMEPA1;SMAD6;LDLRAD4
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5247895071699986,1.4882212054008614,0.050381679389312976,0.6626322922680333,1.0,7/51,7.01%,SLC22A6;SLC22A8;SLC5A5;MCU;TMEM241;SLC5A8;SLC20A2
prerank,serotonin receptor activity (GO:0099589),-0.5478140822764574,-1.4867154272854288,0.038202247191011236,0.2594307622375666,1.0,9/22,15.28%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5478140822764574,-1.4867154272854288,0.038202247191011236,0.2594307622375666,1.0,9/22,15.28%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5478140822764574,-1.4867154272854288,0.038202247191011236,0.2594307622375666,1.0,9/22,15.28%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,ion channel activity (GO:0005216),-0.41941523511915557,-1.4866351598546708,0.013986013986013986,0.2541913765580672,1.0,20/80,9.54%,GRID2;GRIK2;PIEZO2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;ABCC9;GRIA3;UNC80;GRIK4;GRIN3A;TRPC1;GRIN2A;TRPC6;PIEZO1;GRID1;TRPV4
prerank,calcium ion binding (GO:0005509),-0.343002376033671,-1.4838841316059483,0.0,0.2540677321522887,1.0,95/323,18.89%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;ASTN2;CDH8;CDH2;CDH13;GSN;SPOCK2;LTBP4;MCTP1;PLA2G4A;ESYT2;RYR2;RASGRP3;THBS1;TPD52;ACER3;STIM2;IQGAP1;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;ASPN;CALM1;CDH6;MICU3;CALM2;GLCE;ENPP1;TKT;PPP3R1;CDH20;CDH19;CDH7;PAM;PPP3CA;HSPA5;SPOCK1;DYSF;CALR;CRACR2A;S100B;TPM4;CAMKK2;EFHD2;TUBB4A;ESYT3;AGRN;CALM3;ENPP2;SPARCL1;CDH1;ASAH2;S100A16;SNCA;PITPNM3;RET;CETN3;CDK5R1;SDF4;MAN1B1;SYT7;TRPM2;PCP4;GRIN1;CDH9;RASGRP2;AOC3;CLEC3B;AMY1B;AMY1A;AMY1C;AOAH;SYT6;GCA;ITPR3;CETN2;EFCAB11;PLA2G4E;CASQ2;SYT10;EML1;MCTP2
prerank,outward rectifier potassium channel activity (GO:0015271),0.7092880879225342,1.4784248520977386,0.09714285714285714,0.6863184256027861,1.0,4/11,1.80%,KCNK2;KCNT1;KCND3;KCNA5
prerank,thyroid hormone receptor binding (GO:0046966),0.5837553521957073,1.475677913881148,0.07,0.6794275437991519,1.0,15/28,20.46%,BRD8;NSD1;NCOA3;MED12;TRIP12;MED17;TRIP6;THRAP3;TAF11;HMGN3;NCOR1;TAF7;MED1;NCOA6;MED13
prerank,mRNA 3'-UTR binding (GO:0003730),0.4881306594428627,1.473933678321883,0.031161473087818695,0.6686711999789015,1.0,27/79,18.46%,CPEB2;CELF2;DDX5;CPEB4;RBMS2;LARP4B;IGF2BP1;TP53;HNRNPA2B1;PABPC4L;LARP1;CPEB3;IGF2BP2;CSDC2;RBMS1;HNRNPC;RSL1D1;PABPC5;ZFP36L1;RBM4;DAZAP1;ILF3;CRYZ;RBMS3;BOLL;RNF20;LARP4
prerank,ribosomal small subunit binding (GO:0043024),0.634253492861707,1.472494453597588,0.07865168539325842,0.6572642154355914,1.0,3/17,8.30%,CPEB2;DDX3X;LARP1
prerank,ribosomal large subunit binding (GO:0043023),0.6815083736968117,1.4627731605799612,0.06563706563706563,0.6798957560648272,1.0,1/11,0.33%,CPEB2
prerank,phospholipid transfer activity (GO:0120014),-0.5470457069905348,-1.4602531421696319,0.046511627906976744,0.2934716260142428,1.0,9/21,13.42%,CERT1;PITPNC1;PLTP;GLTP;PITPNB;TNFAIP8L3;MTTP;PITPNA;PLEKHA3
prerank,intracellular chloride channel activity (GO:0061778),-0.5833220915797915,-1.4578650805442075,0.06960556844547564,0.28676516902615506,1.0,7/16,15.40%,ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5833220915797915,-1.4578650805442075,0.06960556844547564,0.28676516902615506,1.0,7/16,15.40%,ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,LRR domain binding (GO:0030275),0.6690594520830209,1.455706213636129,0.08080808080808081,0.6914195767596901,1.0,2/14,0.75%,ROBO1;PAWR
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.5531516959655918,1.4552019441356467,0.057947019867549666,0.6768601816218484,1.0,12/32,18.12%,KDM7A;TET2;BBOX1;TMLHE;KDM2B;KDM2A;RIOX2;TET1;HIF1AN;ALKBH5;TET3;PHYH
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.49540699149157263,-1.4551427045491498,0.04632152588555858,0.2862047994501752,1.0,9/32,10.93%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNS3;KCNA6;KCNQ1;KCNC1;KCNB1
prerank,acylglycerol lipase activity (GO:0047372),-0.6404738871214523,-1.4481188921678028,0.07198443579766536,0.29435902243028617,1.0,3/11,13.46%,ABHD2;MGLL;LIPE
prerank,endopeptidase regulator activity (GO:0061135),0.5233432995236036,1.447647745810838,0.061788617886178863,0.6917366785792022,1.0,7/40,9.30%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG;APH1B
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.5370948613177133,-1.4459089789456299,0.06783369803063458,0.2880999053550603,1.0,4/21,16.29%,CDK14;CDK19;CDK8;CDKL4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.5370948613177133,-1.4459089789456299,0.06783369803063458,0.2880999053550603,1.0,4/21,16.29%,CDK14;CDK19;CDK8;CDKL4
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.47327890946899615,-1.4456997748778,0.04578313253012048,0.28348084175352406,1.0,12/35,11.86%,PLCB4;PLCL1;PLCE1;PDE11A;PLCXD3;GPCPD1;ENPP6;ENPP1;GDPD1;PDIA3;ENPP2;SMPDL3A
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5462805967861581,-1.442314688468823,0.05752212389380531,0.2845655408567769,1.0,6/19,13.17%,NRG3;GRM5;EFNA5;GAS6;ABI1;ERCC6
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.6533864580401951,1.4352533043312055,0.09981515711645102,0.7270995840783728,1.0,4/12,12.83%,KDM7A;HR;KDM3B;PHF2
prerank,phosphatidate phosphatase activity (GO:0008195),-0.6112015205948801,-1.4350157346109491,0.06512605042016807,0.2936546554970457,1.0,5/13,13.68%,PLPP1;PLPPR1;PLPPR5;PLPPR4;LPIN3
prerank,sialyltransferase activity (GO:0008373),-0.5418503315781789,-1.430885986214383,0.07079646017699115,0.29679991398062916,1.0,9/20,8.77%,ST6GALNAC3;ST3GAL4;ST8SIA4;ST3GAL1;ST6GAL2;ST8SIA1;ST6GALNAC5;ST3GAL6;ST8SIA6
prerank,phosphotyrosine residue binding (GO:0001784),-0.4674962945992655,-1.4306122459306525,0.05025125628140704,0.29252009773991694,1.0,16/37,23.23%,PIK3R1;NCK2;BCAR3;SHE;PLCG2;CRK;RASA1;PTPN3;SAMSN1;VAV1;SYK;LDLRAP1;IRS1;SHC1;YES1;SHC3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6169592228154621,1.4296443025848817,0.07775768535262206,0.7331220014660427,1.0,5/18,7.88%,ALDH1A2;ALDH1A1;AKR1B10;ALDH3B1;ALDH2
prerank,transcription coactivator binding (GO:0001223),0.5986721297517246,1.427783297386694,0.10986964618249534,0.7245365739529249,1.0,7/20,8.88%,RORA;THRB;SMAD3;VGLL4;CCNT2;TERT;TEAD2
prerank,MAP kinase activity (GO:0004707),0.6562035086959719,1.4271790032066005,0.12407407407407407,0.7114953215675963,1.0,1/14,0.10%,MAPK4
prerank,potassium channel activity (GO:0005267),-0.3941028441851818,-1.4251087575716226,0.02491103202846975,0.29878390914817615,1.0,25/89,11.64%,GRIK2;KCNT2;KCND2;KCNB2;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;GRIK1;KCNN2;ABCC9;KCNQ3;KCNK5;KCNMB2;GRIK4;KCNS3;KCNK13;KCNA6;KCNQ1;KCNK9;KCNC1;KCNH5;KCNB1;KCNK1
prerank,death receptor activity (GO:0005035),-0.604587450039773,-1.4229744540879021,0.0954356846473029,0.29797992329939427,1.0,5/11,18.20%,TNFRSF11A;TNFRSF19;TNFRSF1B;FAS;TNFRSF25
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.6670879823106292,1.4218311165330695,0.13009708737864079,0.7181069219013807,1.0,6/11,19.67%,SLC25A48;SLC25A20;SLC22A5;SLC25A47;SLC25A29;SLC22A4
prerank,ligand-gated cation channel activity (GO:0099094),-0.40065425387386044,-1.4203179431092474,0.04225352112676056,0.2985347758120146,1.0,13/75,4.76%,GRIK2;GRIA4;KCNJ3;GRIK1;GRIN2B;GRIA1;KCNJ2;GRIA2;KCNN2;PTK2B;GRIA3;GRIK4;GRIN3A
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.628273020934466,1.420297019103909,0.10545454545454545,0.7096379737486336,1.0,2/15,1.57%,CCR9;ACKR2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.46547253100166774,-1.408076262715584,0.07792207792207792,0.316647993082821,1.0,13/32,13.39%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7;SFXN3
prerank,nucleotide diphosphatase activity (GO:0004551),0.6334388142277726,1.4065997922236588,0.10576923076923077,0.7516492638636014,1.0,4/14,5.04%,NUDT4;FHIT;CILP2;NUDT13
prerank,kinase activator activity (GO:0019209),0.5446179532644896,1.402213821440562,0.09136212624584718,0.7539451152257436,1.0,2/30,2.35%,PRKAG2;GPRC5C
prerank,carboxylic acid binding (GO:0031406),-0.4509612634671121,-1.3958181476207978,0.05390835579514825,0.33624250244185233,1.0,14/38,15.27%,GRM7;NOS3;SESN3;GRIN2B;GLRB;GRIN3A;GLRA3;PSAP;EPDR1;GLRA1;GLUD1;NOS1;GLRA2;GRIN1
prerank,ubiquitin-specific protease binding (GO:1990381),0.5983183577942527,1.3941482707104915,0.1310344827586207,0.7721742535548995,1.0,10/19,23.60%,PRKN;LCOR;PTEN;CLTC;AMFR;SYVN1;SUMO1;DERL1;SELENOS;BAG6
prerank,organic anion transmembrane transporter activity (GO:0008514),0.4271592533522382,1.3918925046699082,0.044,0.7670476703610065,1.0,20/134,8.49%,SLC22A6;SLC13A3;SLC6A13;SLC6A1;SLC16A12;SLC16A11;SLC38A3;SLC7A2;PDPN;SFXN2;SLC6A9;SLC26A3;SLC25A23;SLC25A2;SLC19A1;SLC27A1;SLC26A1;SLC38A1;SLC1A3;CTNS
prerank,methylated histone binding (GO:0035064),0.4763771289133895,1.383390252794118,0.07396449704142012,0.7861244227338341,1.0,18/62,18.47%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;TAF7;MORC4;LRWD1;NCAPD3;SGF29;KMT2E;CHD8;TAF1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4388045837025102,-1.3765640415296956,0.07035175879396985,0.3723769677949549,1.0,17/42,21.39%,PIK3R1;NCK2;BCAR3;SHE;YWHAE;YWHAB;PLCG2;CRK;RASA1;PTPN3;SAMSN1;VAV1;SYK;LDLRAP1;IRS1;SHC1;YES1
prerank,actinin binding (GO:0042805),0.5717589884593018,1.3735878934545058,0.12299465240641712,0.8129081310867254,1.0,5/21,4.75%,CACNA1D;KCNA5;CSRP3;DAG1;CACNA1C
prerank,monocarboxylic acid binding (GO:0033293),0.5831106489427899,1.3731814301211596,0.13903743315508021,0.7998641565041577,1.0,3/18,4.66%,NAPEPLD;NR2F2;CYP26B1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5975119865482259,-1.3725574824321307,0.1111111111111111,0.37552709975084547,1.0,8/11,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;ATP8B2;ABCB4
prerank,lipid phosphatase activity (GO:0042577),-0.5566995879149845,-1.3683118089225546,0.08779443254817987,0.3795928392469853,1.0,4/14,10.21%,PLPP1;PLPPR1;PLPPR5;PLPPR4
prerank,potassium:proton antiporter activity (GO:0015386),-0.6216672933733661,-1.3671573238371422,0.11776859504132231,0.3768499186478889,1.0,3/10,8.67%,SLC9A2;SLC9A6;SLC9A7
prerank,transforming growth factor beta receptor binding (GO:0005160),0.596086507684162,1.364880795687377,0.1206581352833638,0.8204201867690849,1.0,5/18,7.33%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49372930779924523,1.3643598370687497,0.10310965630114566,0.8078960819372768,1.0,21/44,18.15%,KMT2A;CXXC1;SMYD3;KMT5C;NSD1;KMT5B;SETD7;NSD3;ASH2L;KMT2C;WDR82;KMT2D;KMT5A;DOT1L;SETD1B;SETDB2;EHMT2;EHMT1;ASH1L;KMT2E;SETD3
prerank,voltage-gated ion channel activity (GO:0005244),-0.5559125068008512,-1.3643461244456292,0.10547667342799188,0.377637153658159,1.0,9/14,22.95%,KCND2;CACNA1E;HCN1;VDAC1;CACNA1H;GPR89A;GPR89B;VDAC3;HVCN1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6226222280937525,1.3634198253675658,0.14204545454545456,0.7974328837567066,1.0,4/12,13.29%,SULF2;ARSG;ARSB;SULF1
prerank,vitamin D receptor binding (GO:0042809),0.6165699194103813,1.3615737675112707,0.15700934579439252,0.7913449820095075,1.0,9/14,24.29%,MED12;MED17;THRAP3;TAF11;TAF7;RXRA;MED1;MED13;MED24
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.39968394620301534,-1.3595886997516609,0.06179775280898876,0.38347545828749774,1.0,18/60,9.84%,TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;EPHA6;TIE1;ACVRL1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;FLT4;ERBB2
prerank,protein tyrosine kinase activity (GO:0004713),-0.3612881388520133,-1.3587688878883661,0.02877697841726619,0.3799491021841465,1.0,26/108,10.49%,TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;PEAK1;EPHA6;TIE1;PTK2B;NTRK2;KDR;LYN;ROR2;BMX;MET;EPHA7;EPHB2;PTK2;TEC;JAK1;FLT4;ERBB2;CAMKK2;HIPK1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4516202471957404,1.357791576313895,0.08946608946608947,0.793233193035831,1.0,12/74,9.40%,NADK2;FAM20A;HK2;SPHK1;PI4KA;GK5;TKFC;GALK2;GK;PANK1;PIK3CA;DCAKD
prerank,muscle alpha-actinin binding (GO:0051371),-0.5558062834853323,-1.3559759565571228,0.12276785714285714,0.38099785599847635,1.0,8/15,30.32%,PDLIM1;SYNPO2;PDLIM3;LDB3;PDLIM2;TTN;PDLIM4;NRAP
prerank,NAD+ binding (GO:0070403),0.6322112797305315,1.3545031941428174,0.15625,0.792670197538151,1.0,6/12,9.50%,CRYL1;SIRT5;SIRT3;PARP9;SIRT1;ZC3HAV1
prerank,carbohydrate kinase activity (GO:0019200),0.6347584349395354,1.3545012681173418,0.16061185468451242,0.7798851943520518,1.0,6/11,23.83%,HK2;GALK2;GALK1;HK1;NAGK;GNE
prerank,amino acid transmembrane transporter activity (GO:0015171),0.48781322388779025,1.3537718843673583,0.11165048543689321,0.7701545624987699,1.0,7/47,3.72%,SLC6A13;SLC6A1;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN
prerank,metal ion binding (GO:0046872),-0.30666981726194203,-1.3534201821298086,0.0,0.3814098905734349,1.0,133/477,19.06%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;MARK1;ASTN2;CDH8;CDH2;CSGALNACT1;CDH13;GSN;SPOCK2;LTBP4;SNRK;MAP3K5;HMGCLL1;MCTP1;PLA2G4A;ESYT2;ADCY2;RYR2;RASGRP3;THBS1;CDC42BPA;TPD52;ACER3;STIM2;IQGAP1;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;NLK;ASPN;CALM1;CDH6;APOE;MICU3;CALM2;GLCE;GNAI1;ENPP1;TKT;PPP3R1;CDH20;CDH19;CDH7;PAM;PPP3CA;HSPA5;SPOCK1;DYSF;CALR;IRAK3;CRACR2A;PDE2A;S100B;RAP2A;TPM4;CAMKK2;EFHD2;TUBB4A;ESYT3;AGRN;CALM3;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;ENPP2;SPARCL1;TRIM27;MARK2;CDH1;ASAH2;S100A16;SNCA;DUT;PITPNM3;RPE;RET;CETN3;PINK1;CDK5R1;SDF4;MT3;MAN1B1;SYT7;MAPK12;TRPM2;PCP4;GRIN1;CDH9;RASGRP2;AOC3;CLEC3B;PDXK;TOP2A;TPPP;ENDOV;AMY1B;AMY1A;AMY1C;AOAH;SYT6;GCA;ITPR3;CETN2;EFCAB11;PLA2G4E;CASQ2;HPRT1;IMPA1;SYT10;HSPE1;EML1;EXD2;MCTP2;RHEB;RAN
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.48834126960892316,-1.3524726637643738,0.11298076923076923,0.3785592364823127,1.0,6/23,9.32%,PLCB4;EDNRA;PLCE1;CHRM3;PLCG2;PLCH1
prerank,acetyltransferase activity (GO:0016407),0.5198809090109633,1.3480492152045394,0.10252100840336134,0.7797945076707109,1.0,9/31,16.30%,SPHK1;PAFAH2;NAA80;SAT1;KAT6B;SMARCE1;KAT2B;NAA16;CREBBP
prerank,pre-mRNA binding (GO:0036002),0.5287647300600742,1.3464781853877392,0.1245674740484429,0.7737358033670272,1.0,2/28,1.27%,CELF2;DDX5
prerank,methylation-dependent protein binding (GO:0140034),0.47079297305956014,1.3453633423638434,0.10291858678955453,0.7662463596277577,1.0,16/57,18.45%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;MORC4;LRWD1;NCAPD3;SGF29;KMT2E;CHD8
prerank,nuclear receptor binding (GO:0016922),0.42280125132779023,1.3432468197526934,0.07123655913978495,0.7624010018166633,1.0,26/111,11.90%,PPARGC1B;SMAD3;DDX5;PPARGC1A;BRD8;NCOR2;PRKCB;NSD1;NCOA3;LCOR;HMGA1;BCAS3;MED12;WIPI1;SMARCD3;TRIP12;SMARCA4;TMF1;SMARCE1;SIRT1;TCF7L2;MED17;TRIP6;THRAP3;TAF11;CCDC62
prerank,histone acetyltransferase activity (GO:0004402),0.5233701735489218,1.3416039719366881,0.12687813021702837,0.7570575417328366,1.0,11/30,18.47%,ARRB1;NCOA3;SRCAP;KAT6B;ATF2;BAZ1A;KAT14;KAT7;KAT2B;CREBBP;TAF1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.6050189384940334,-1.3415733346668084,0.1206896551724138,0.3979534522200957,1.0,3/11,4.51%,KCNMA1;KCNN2;KCNMB2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.5436980878343609,-1.34127741453738,0.1452991452991453,0.39347499807538017,1.0,4/15,23.28%,PLA2G4A;PLA2G12A;PLA2G4E;PLA2G4F
prerank,insulin-like growth factor I binding (GO:0031994),-0.5664417837047049,-1.3396304842244413,0.14315352697095435,0.39178598765806294,1.0,5/13,10.38%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3593042791711904,1.3391479036027258,0.0020768431983385254,0.7553797161136767,1.0,141/830,12.98%,AEBP1;EPAS1;HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;TFDP2;GLIS3;OSR1;ZIC2;MXI1;NFYC;CUX1;PPARA;PKNOX2;CREBRF;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;NPAS3;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;VEZF1;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;NFYB;NHLH2;FOXP2;SALL4;CUX2;RREB1;MEIS1;NSD1;TEF;OTP;ESRRA;TEAD3;STAT2;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;RBL2;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TFDP1;TCF7;NR2C2;HDAC1;SOX13;CCAR1;ZFP90;FOXC2;TCF7L2;TCF4;HBP1;ZBTB8B;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;RBL1;ZFP3;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;DEAF1;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,nuclear receptor coactivator activity (GO:0030374),0.47267415985803607,1.3363234017062233,0.11829652996845426,0.7554298697074435,1.0,15/52,11.90%,PPARGC1B;PPARGC1A;BRD8;PRKCB;NCOA3;HMGA1;MED12;TMF1;CALCOCO1;CCAR1;MED17;THRAP3;ZMIZ2;ZMIZ1;CCDC62
prerank,alpha-actinin binding (GO:0051393),0.5465517231512096,1.335858837789823,0.13380281690140844,0.74665874742602,1.0,4/24,4.75%,CACNA1D;KCNA5;DAG1;CACNA1C
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6477100893269775,1.3347116035706799,0.17333333333333334,0.7405324661137918,1.0,1/10,0.09%,SLC22A6
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6240020676424287,1.3334371017973425,0.15808823529411764,0.7349182585831728,1.0,2/13,0.46%,BMP6;BMP7
prerank,chloride channel inhibitor activity (GO:0019869),0.630733328673071,1.330994565454435,0.145748987854251,0.7335171475839083,1.0,1/10,0.45%,WNK4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.6000643961821831,1.3272902183053923,0.17647058823529413,0.737219370348722,1.0,5/15,4.33%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5580741835386904,-1.3271354853957291,0.1320754716981132,0.4134016525644525,1.0,7/13,18.17%,PTPRJ;IL1R1;PDGFC;PDGFA;ITGB3;VEGFA;ITGA5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.581718011116164,1.3265968205360632,0.17335766423357665,0.7298336123708596,1.0,8/16,27.68%,ALOX12;ADI1;BCO2;ETHE1;ALOXE3;CDO1;HAAO;PIR
prerank,adenylyltransferase activity (GO:0070566),0.5513955016053926,1.3254853280166465,0.151183970856102,0.7242844879781682,1.0,13/21,22.77%,OAS2;NMNAT1;TENT2;FLAD1;ABL1;OAS3;TENT4B;PAPOLG;NMNAT2;TUT1;SELENOO;KARS1;NMNAT3
prerank,MHC class II protein complex binding (GO:0023026),-0.5864506261324727,-1.3245504412271218,0.14959016393442623,0.4138977649974068,1.0,7/11,17.31%,ATP1B1;YWHAE;HSP90AB1;HSPA8;HSP90AA1;PKM;CD74
prerank,Toll-like receptor binding (GO:0035325),-0.5752407202379892,-1.3103665349037719,0.17484008528784648,0.43990919549899204,1.0,7/11,34.07%,DAB2IP;TIRAP;CD36;TOLLIP;TLR1;TLR2;MYD88
prerank,BMP receptor binding (GO:0070700),0.6240023514230513,1.3099426074387424,0.17407407407407408,0.7688389044416172,1.0,2/12,0.46%,BMP6;BMP7
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.4662533848588317,1.3073296226360702,0.14152410575427682,0.7689165501407677,1.0,3/48,1.13%,TRPM3;SLC41A1;TRPM6
prerank,rRNA binding (GO:0019843),-0.4170371939897566,-1.3021404479623262,0.12,0.45291710002711516,1.0,20/42,26.10%,CAVIN1;RPLP0;RPS3;RPL5;RPL12;RPS9;RPL23;RPS5;EMG1;NOP53;RCC1L;MRPL16;ERI1;UTP23;RPS13;RPL11;FASTKD5;RRS1;DDX28;FASTKD2
prerank,metalloexopeptidase activity (GO:0008235),0.47020587994539326,1.3013060507305567,0.13009404388714735,0.7799735505376711,1.0,13/51,15.78%,AEBP1;ACE;CPQ;CPA4;METAP2;PEPD;NPEPPS;MMP14;FOLH1;ERAP1;AGBL3;ZMPSTE24;ANPEP
prerank,G protein-coupled receptor binding (GO:0001664),0.4002892062904968,1.3012073498352745,0.06933333333333333,0.7705924333550631,1.0,17/132,10.18%,WNT5B;ACE;RNF43;WNT4;TULP3;WNT6;PRKN;GNAT2;ARRB1;ARHGEF11;ARHGEF12;GNAT3;RYK;GPRC5B;ADM;PICK1;CCL25
prerank,P-type ion transporter activity (GO:0015662),-0.5480132930107371,-1.2994576773317075,0.15702479338842976,0.4534922328525465,1.0,5/12,11.59%,ATP2C1;ATP2B2;ATP2A3;ATP2B4;ATP2B1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.37739345938850216,1.298428018663722,0.06674907292954264,0.7709277869999146,1.0,33/232,11.43%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;PIAS1;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;HUWE1;TRIP12;RNF217;RNF19A;RNF34;UBR5;SH3RF1;RNF41;RNF13;CDC42;WWP2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3779176653611008,1.2973566405094847,0.06125,0.7653331346973001,1.0,32/228,11.43%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;HUWE1;TRIP12;RNF217;RNF19A;RNF34;UBR5;SH3RF1;RNF41;RNF13;CDC42;WWP2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.46335264650092994,-1.2969615197787085,0.14385150812064965,0.45428736989448526,1.0,9/23,5.56%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE7B;PDE1C
prerank,C-C chemokine receptor activity (GO:0016493),0.5336875975886077,1.292222845079227,0.17025089605734767,0.7737045073964512,1.0,2/21,1.57%,CCR9;ACKR2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4378820502783885,1.2903765683008808,0.13082706766917293,0.7712361108133999,1.0,15/60,14.70%,LRRK1;CTDSPL;MTMR3;PPEF2;PPP1CB;PPM1E;LRRK2;CDC14A;PTEN;PP2D1;CDC14B;PHLPP2;CTDSP2;PPM1B;CTDP1
prerank,androgen receptor binding (GO:0050681),0.5133065727297039,1.288737544085316,0.18006993006993008,0.7676329606670854,1.0,6/25,8.51%,DDX5;PRKCB;NSD1;WIPI1;SMARCA4;TMF1
prerank,GTPase activator activity (GO:0005096),0.3621366057633867,1.288505788878215,0.042725173210161664,0.759549016153539,1.0,72/313,13.69%,RANBP3L;DENND4A;DOCK11;RAPGEF5;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;ARHGEF18;FNIP1;ARHGEF16;SRGAP2;ARHGAP18;FGD4;SYDE2;RGL1;ARHGAP9;ALS2;ALDH1A1;DOCK5;NGEF;NPRL3;AKAP13;RGS16;TBC1D16;ASAP3;LRRK2;GMIP;RAPGEF3;ARHGAP26;DENND2A;RAB3IP;IQSEC2;ARRB1;WDR41;RIN3;ASAP1;NPRL2;RAB3IL1;ARHGAP17;ARFGEF2;ARHGEF11;ARFGAP3;ELMOD3;DENND5A;SH3BP5;NUCB1;DNM1L;EPS8L2;OPHN1;GRTP1;HPS1;RALGAPB;FGD1;MTSS2;RANBP3;OCRL;RALBP1;EPS8L1;RGPD1;RGP1;GNB5;ANKRD27;RIC8B;MON1A;RAP1GAP;HACD3;DENND4C;DEPDC5
prerank,anion transmembrane transporter activity (GO:0008509),0.6080664150213572,1.2876990428489714,0.21218074656188604,0.7536819479112451,1.0,2/12,5.93%,SLC22A6;SLC19A1
prerank,tropomyosin binding (GO:0005523),0.5703321891253093,1.2847656921252724,0.20917431192660552,0.7550731452861889,1.0,3/16,5.15%,NEBL;TMOD2;TMOD3
prerank,N-acyltransferase activity (GO:0016410),0.4877150896169756,1.2841700335270252,0.15859766277128548,0.748559729154897,1.0,7/32,9.34%,NMT2;NAA80;CERS6;CERS5;SAT1;SMARCE1;SIRT1
prerank,DNA binding (GO:0003677),0.3463050099828369,1.284064057381599,0.014583333333333334,0.7407203953488678,1.0,176/694,20.44%,DENND4A;EPAS1;HLF;RORA;THRB;SMAD3;APLP2;ZIC2;PPARGC1A;NFYC;CUX1;PPARA;SSBP2;SPO11;POLR2A;ZNF423;DNMT3A;GLI2;SPHK1;FOXD1;HOXA1;ARID4A;NUPR1;NR2F2;TSHZ3;NR6A1;CXXC5;FOXC1;NFIB;PCBP2;ASCL3;NFYB;FOXP2;CUX2;CHD4;TIGD3;MEIS1;POLG;DDX3X;OTP;ARID3A;NHEJ1;ESRRA;HMGA1;TP53;TSHZ1;COLEC11;BCLAF3;CAMTA2;DNASE1L1;SOX12;PARP4;POLR2D;HUWE1;SAMHD1;MEF2A;KDM2B;SMARCA4;FBH1;TWNK;TERT;SLTM;SIRT3;XRCC4;IRX1;CALCOCO1;HDAC4;SSBP1;GLI1;C1D;RBMS1;ZIC4;NR2C2;DDX60;SOX13;WDR76;FOXC2;TCF7L2;TCF4;ZNF219;HIVEP2;FOXL1;SURF6;THRAP3;ABL1;PRDM5;RTF1;ZBTB6;MAU2;ZDHHC1;RARG;RBBP8;PRKDC;MSH3;TEAD1;ZNF148;IGHMBP2;HOXB2;FOXA2;MLXIPL;RAD50;TOP3A;PNKP;TDG;IRF1;PHF1;KMT2D;PBX4;MTERF2;ZMYM6;MCM7;MCM2;DDB2;MBD6;PSIP1;TAF4;ZBTB32;ILF2;SDE2;ZKSCAN3;HOXA7;E2F4;PURB;DEDD;TDP2;TET1;ZMYM4;FUBP3;NKX2-1;POLL;RXRA;DNASE1L2;RFX2;CREBBP;CENPC;CLSPN;ILF3;SMAD4;TCF7L1;MBD4;BARX2;CHD2;MSH4;CRY1;OGG1;TINF2;EZH1;FOXO3;CHD8;TAF1;HES7;NBN;FEN1;MBD1;FOXD2;RAD51D;CARF;ZGPAT;PDS5B;APTX;RFC1;POU4F1;HDGFL2;XPA;BCL6;ZNF76;NR1H3;RTF2;LIG4;NR5A1;GTF3C3;SPDEF;MCM9;IKZF3;POLR2G;GTF2A1
prerank,5'-nucleotidase activity (GO:0008253),0.5976194582322352,1.2817303532595083,0.1950286806883365,0.7400001478009713,1.0,7/13,18.54%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,transcription cis-regulatory region binding (GO:0000976),0.3578699074794073,1.2771109458247973,0.04065934065934066,0.7483741901718431,1.0,83/406,16.45%,AEBP1;EPAS1;RORA;SMAD3;TFDP2;OSR1;FOXN3;MXI1;NFYC;CUX1;CREBRF;ZBTB20;NPAS3;GABPB1;GABPB2;ZNF568;ARID4A;SOX5;GLI3;FOXC1;VEZF1;ASCL3;NFYB;CREB3L2;SMAD6;CUX2;RREB1;BNC2;OTP;TIPARP;HMGA1;TP53;TBL1X;SOX12;BCOR;MEF2A;RBL2;TBL1XR1;CALCOCO1;HDAC4;GLI1;TFDP1;TCF7;NR2C2;HDAC1;SOX13;ASH2L;ZFP90;FOXC2;TCF7L2;ZBTB8B;RBL1;ZFP3;PRDM5;MNT;ATF2;HNRNPL;TFAP2D;TEAD1;BRD7;FOXA2;DEAF1;IRF1;KMT2D;ZBTB48;TBP;ATF6B;TAF4;NCOR1;SNAI1;PER2;NFKB1;PURB;TAF7;HOXB8;HSF2;MZF1;NKX2-1;STAT6;RXRA;ZBTB8A;RB1;PER3
prerank,sequence-specific DNA binding (GO:0043565),0.34449467960913727,1.2743216458352777,0.01995798319327731,0.7499403292886643,1.0,87/590,12.44%,EPAS1;HLF;RORA;MAF;THRB;SMAD3;OSR1;PPARGC1A;CUX1;KMT2A;PPARA;PKNOX2;ZNF423;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;CXXC1;FOXD1;HOXA1;NFAT5;NR2F2;ELF1;NR6A1;GLI3;ARNT2;CXXC5;FOXC1;CXXC4;NFIB;ZBTB38;MAFG;ATOH1;MBNL2;SMG1;NHLH2;FOXP2;CUX2;FBXL19;TEF;ACD;ESRRA;HOXB9;HOXB5;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;ELF2;MEF2A;KDM2B;NR1D2;HOXC4;ZIC1;KDM2A;TERT;SLTM;SIRT3;IRX1;TEAD2;KLF3;CALCOCO1;HDAC4;ZBTB26;ZIC4;TCF7;NR2C2;SOX13;FOXC2;TCF7L2;TCF4;FOXL1;ABL1;PRDM5;NFATC3;RARG;ATF2;SKOR1;MYBL2;TEAD1;ZNF148;HES6;HOXB2;FOXA2;NR3C2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.46536104698658814,-1.2723753038031893,0.13138686131386862,0.5064332756472659,1.0,10/23,19.58%,HIP1;CLVS1;PLEKHA5;JPH2;SESTD1;PHLDA3;CLVS2;PLA2G4E;HIP1R;COMMD1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3413391143877078,1.2721551483165365,0.008359456635318705,0.7486908105028636,1.0,125/731,12.98%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;FOXN3;MXI1;NFYC;PPARA;PKNOX2;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;ZBTB38;MAFG;ATOH1;NACC2;NFYB;NHLH2;FOXP2;SALL4;RREB1;MEIS1;NSD1;TEF;TIPARP;ESRRA;TEAD3;STAT2;HMGA1;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;HDAC1;SOX13;CCAR1;FOXC2;TCF7L2;TCF4;HBP1;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,ADP binding (GO:0043531),0.5249655165254866,1.2710250709642423,0.1875,0.7446822120946067,1.0,2/25,4.14%,PRKAG2;MYO18A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.464992785409085,-1.2680046240381995,0.15730337078651685,0.5112334282227388,1.0,9/21,5.56%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE7B;PDE1C
prerank,phosphoric ester hydrolase activity (GO:0042578),0.45273420457928454,1.2671863067067377,0.1620745542949757,0.7493363335721056,1.0,9/49,10.90%,ATP1A2;MPPED2;PPP1CB;LHPP;PXYLP1;PTPN22;SAMHD1;PRUNE1;DUSP10
prerank,flavin adenine dinucleotide binding (GO:0050660),0.44618007841871743,1.2657150770163164,0.1626865671641791,0.7466952958153765,1.0,19/53,18.94%,DDO;MICAL3;PRODH;DPYD;POR;MTHFR;DLD;LDHD;NOX4;ACOXL;MTRR;GCDH;ACOX3;SQOR;MICAL1;KDM1A;CRY1;MMACHC;ETFDH
prerank,actin binding (GO:0003779),-0.3166412731241849,-1.2628880512379788,0.04329004329004329,0.5177516461355572,1.0,46/170,13.54%,UTRN;SYNE1;ACTN4;MYRIP;MAP1B;GSN;ABLIM1;TMSB4X;FMN2;KCNMA1;NOS3;PARVB;MICAL2;FXYD5;MOBP;KLHL2;CCDC88A;MYH9;CAP2;LIMA1;SMTN;KLHL1;MRTFA;CORO2B;ITGB1;PTK2;RDX;ANLN;CEACAM1;PDLIM1;MYO6;TRPV4;ADD2;TLNRD1;PACRG;EPS8;CALD1;SYNPO2;SPEF1;MAPT;PFN2;MTSS1;PDLIM3;DMTN;SNCA;SPTB
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5374129666390159,-1.260671793412063,0.19205298013245034,0.5173541013982144,1.0,7/12,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,bHLH transcription factor binding (GO:0043425),0.5403055128382711,1.260060207812763,0.2224334600760456,0.7578954678000148,1.0,4/19,9.34%,SMAD3;FHL2;BHLHE41;SIRT1
prerank,tRNA methyltransferase activity (GO:0008175),0.5466153457919927,1.2560943333578116,0.2278719397363465,0.763242779895963,1.0,2/16,7.48%,TRMT9B;TRMT44
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.49857536186329027,1.2552230160383993,0.18717504332755633,0.758989987770167,1.0,1/29,0.04%,PRKAG2
prerank,MAP-kinase scaffold activity (GO:0005078),0.588795372297422,1.2545426533542439,0.2222222222222222,0.7537563041445763,1.0,5/11,14.01%,KSR1;AKAP13;SH3RF1;MAP2K1;MAP2K2
prerank,protein kinase regulator activity (GO:0019887),0.3967798216719229,1.2522685257695227,0.12624113475177304,0.7535329049337781,1.0,21/95,16.59%,PRKAG2;GPRC5C;CCNA2;PRKAG3;CCNA1;CCNT2;CCND3;SH3BP5;GPRC5B;CCNB2;TRIB1;SOCS3;GPRC5A;WNK1;PRKAR1A;PARVA;CCNG1;FAF1;CCNL1;RPTOR;CCNE1
prerank,voltage-gated cation channel activity (GO:0022843),-0.34211748942898434,-1.2517227563304991,0.08812260536398467,0.5337832808118905,1.0,23/97,11.64%,KCND2;CACNB2;KCNB2;CACNA1E;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;CACNA2D1;GRIN2B;KCNQ3;PTK2B;GRIN3A;KCNS3;GRIN2A;CACNA1B;KCNA6;KCNQ1;KCNC1;KCNH5;KCNB1;KCNK1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.38914385508298505,-1.2513148422640985,0.12335958005249344,0.5289973171663452,1.0,12/46,12.19%,MGAT4C;GCNT2;EXT1;MGAT4A;B3GALT1;HEXB;MGAT5;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,potassium channel regulator activity (GO:0015459),-0.3769079678550977,-1.250972948578745,0.14130434782608695,0.5239054376685011,1.0,12/49,7.27%,KCNIP4;DPP10;DPP6;ABCC9;KCNIP1;KCNAB1;KCNMB2;NEDD4L;YWHAE;KCNS3;FLNA;WNK2
prerank,myosin II binding (GO:0045159),-0.5581251712810256,-1.2469583168514509,0.22199170124481327,0.5279732379436142,1.0,4/10,9.85%,GSN;STXBP5L;SHROOM4;SHROOM1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3344408639634523,1.2463042295189177,0.020876826722338204,0.7660908420841337,1.0,123/730,12.98%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;MXI1;NFYC;PPARA;PKNOX2;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;ZBTB38;MAFG;ATOH1;NACC2;NFYB;CREB3L2;NHLH2;FOXP2;SALL4;RREB1;MEIS1;NSD1;TEF;ESRRA;TEAD3;STAT2;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;HDAC1;SOX13;CCAR1;FOXC2;TCF7L2;TCF4;HBP1;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,C-C chemokine binding (GO:0019957),0.5113672175925238,1.2456623437383851,0.19718309859154928,0.7607380345050101,1.0,2/22,1.57%,CCR9;ACKR2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5131491886980335,-1.2443498604391043,0.20135746606334842,0.5284911889098365,1.0,6/13,17.40%,CCDC88A;ARHGDIB;SH3BP4;RANBP1;ARHGDIA;GDI1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.433749190545141,1.2439872227908793,0.16589861751152074,0.7587766767787982,1.0,11/54,9.55%,UPB1;ASPA;HDAC8;NGLY1;ASPG;PM20D1;NAAA;SIRT5;HDAC4;SIRT1;HDAC1
prerank,sodium channel regulator activity (GO:0017080),-0.4019311125521357,-1.2419368242726407,0.14540816326530612,0.5287057001328164,1.0,14/37,21.74%,FGF14;FGF12;CAMK2D;FXYD5;NEDD4L;FGF13;ATP2B4;PTPN3;NOS1;SCN2B;FXYD6;COMMD1;SCN1B;PKP2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5405555866498185,-1.241819280768777,0.21951219512195122,0.5234258041570515,1.0,2/11,7.01%,MAP3K5;MAP3K7
prerank,potassium ion leak channel activity (GO:0022841),0.5500651899621437,1.238087620808869,0.21903052064631956,0.7711965456950315,1.0,1/15,0.26%,KCNK2
prerank,filamin binding (GO:0031005),0.5826694801330261,1.2377966314934536,0.2495201535508637,0.7649493062162146,1.0,1/11,0.50%,NEBL
prerank,chloride channel regulator activity (GO:0017081),0.5524620848993248,1.2357963277073163,0.23180076628352492,0.764303539000367,1.0,1/14,0.45%,WNK4
prerank,calcium channel regulator activity (GO:0005246),-0.40244329740190127,-1.2346487745217223,0.1715686274509804,0.5358440620925474,1.0,12/37,15.66%,PRKG1;NRXN1;STIM2;YWHAE;CALM1;CALM2;FKBP1A;NRXN2;SLC30A1;MCUB;CACNG8;STIMATE
prerank,FAD binding (GO:0071949),0.5093331266660924,1.2342340193267671,0.22086956521739132,0.7624176407119622,1.0,9/24,18.08%,DDO;MICAL3;PRODH;MTHFR;MTRR;SQOR;MICAL1;CRY1;MMACHC
prerank,insulin-like growth factor binding (GO:0005520),-0.5099411855443818,-1.233962071561381,0.18843683083511778,0.5318144229975557,1.0,5/15,10.38%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,transcription coregulator binding (GO:0001221),0.43920251071722416,1.2339139204277103,0.19806763285024154,0.7564002239137299,1.0,16/50,17.01%,RORA;THRB;SMAD3;VGLL4;LCOR;USP11;CCNT2;TERT;TEAD2;PHF1;PER2;EHMT2;PER3;EHMT1;SMAD4;CTBP2
prerank,poly-pyrimidine tract binding (GO:0008187),0.4954659115922714,1.2303069646876619,0.22185430463576158,0.7606674344772698,1.0,10/23,21.20%,RBMS2;HNRNPH1;PABPC4L;RBMS1;HNRNPC;PABPC5;DAZAP1;RBMS3;FMR1;U2AF2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5277225015233311,-1.2244544535279223,0.21888412017167383,0.5497820817539931,1.0,6/12,18.17%,VEGFC;CCDC88A;DAB2IP;ITGB3;VEGFA;ITGA5
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5478034470753379,-1.2240106758550193,0.21839080459770116,0.5453958958834768,1.0,2/10,5.64%,MECOM;PRDM16
prerank,low-density lipoprotein particle binding (GO:0030169),-0.49620200630542466,-1.223058572433287,0.24093816631130063,0.5423249453800744,1.0,8/16,9.02%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5406519425024019,-1.2201757435955134,0.23387096774193547,0.5440919823426753,1.0,4/10,8.39%,DPP10;DPP6;FAP;NAALAD2
prerank,actin monomer binding (GO:0003785),-0.4463144015848749,-1.219574560731513,0.20238095238095238,0.5402067885761586,1.0,7/22,15.91%,TMSB4X;NOS3;LIMA1;MRTFA;PFN2;MTSS1;COBL
prerank,calcium activated cation channel activity (GO:0005227),-0.4895332705968042,-1.2186516625285935,0.21462264150943397,0.537398384846339,1.0,4/17,4.51%,KCNMA1;ANO1;KCNN2;KCNMB2
prerank,GDP binding (GO:0019003),-0.35922245915263395,-1.2185279658240133,0.146875,0.5325260746218042,1.0,18/63,19.06%,RIT2;RAB31;KRAS;RAP1B;RAP1A;RASL12;RAB27A;GNAI1;RERG;RALB;RAP2A;RAB18;RAB27B;RRAS;ARF6;ARL8B;RHEB;RAN
prerank,MAP kinase phosphatase activity (GO:0033549),0.5559362508242917,1.2158307846954284,0.24550898203592814,0.7992833835036879,1.0,4/12,18.07%,DUSP29;DUSP10;DUSP2;DUSP4
prerank,poly(U) RNA binding (GO:0008266),0.510353928857775,1.214397991016042,0.23580034423407917,0.7969628394611535,1.0,8/20,17.54%,RBMS2;HNRNPH1;PABPC4L;RBMS1;HNRNPC;PABPC5;DAZAP1;RBMS3
prerank,lipoprotein particle binding (GO:0071813),-0.4614314484543436,-1.2127598161232285,0.22657952069716775,0.5415474965975375,1.0,8/20,9.02%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,hormone receptor binding (GO:0051427),-0.4942853124863919,-1.212161440330942,0.21973094170403587,0.5379611878557778,1.0,3/14,12.44%,SOCS2;JAK1;PTHLH
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3656918513778089,1.2118843906177115,0.12567567567567567,0.7975844855340597,1.0,26/147,8.93%,DENND4A;DOCK11;RAPGEF5;RIN2;ARHGEF18;FNIP1;ARHGEF16;FGD4;RGL1;ALS2;DOCK5;NGEF;AKAP13;RAPGEF3;DENND2A;RAB3IP;IQSEC2;WDR41;RIN3;RAB3IL1;ARFGEF2;ARHGEF11;DENND5A;SH3BP5;NUCB1;EPS8L2
prerank,chemokine receptor activity (GO:0004950),0.49284523248817325,1.2112976123754515,0.23497267759562843,0.7925890864122028,1.0,2/24,1.57%,CCR9;ACKR2
prerank,semaphorin receptor activity (GO:0017154),-0.537087280182213,-1.210919520394861,0.2332657200811359,0.5361414614286751,1.0,4/11,8.86%,NRP1;NRP2;PLXNC1;PLXNA4
prerank,sterol binding (GO:0032934),0.4124590313129278,1.2097577636942043,0.19909502262443438,0.7907289017432747,1.0,10/56,9.11%,RORA;OSBPL8;GRAMD1B;INSIG2;VDAC2;OSBPL11;OSBPL9;RORC;SIDT1;SULT2B1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5226107957662931,-1.20878965574106,0.2515463917525773,0.5357483104774189,1.0,2/12,7.63%,PIEZO2;PIEZO1
prerank,protein kinase activator activity (GO:0030295),0.4240416511733712,1.2047661520313437,0.2119309262166405,0.7991051034154351,1.0,16/60,15.83%,PRKAG2;FAM20A;GPRC5C;ALS2;DDX3X;AFAP1L2;RICTOR;NRG1;GPRC5B;IRGM;GPRC5A;WNK1;MAP2K1;MAP2K2;STK4;RPTOR
prerank,GABA receptor binding (GO:0050811),0.5519065512931599,1.202323327843131,0.26011560693641617,0.800228438057607,1.0,3/11,10.10%,TRAK1;ARFGEF2;SHISA7
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5228036876038292,-1.2018551660495644,0.2543478260869565,0.546722278490721,1.0,6/11,31.97%,RPS3;HMCES;HMGA2;APEX1;APEX2;NEIL2
prerank,carboxypeptidase activity (GO:0004180),0.4610679878998921,1.2014354453866192,0.2306368330464716,0.7962654043967493,1.0,5/35,7.47%,AEBP1;CPA4;NAALADL1;PEPD;SCPEP1
prerank,calcium-release channel activity (GO:0015278),0.5142738550541012,1.1963517671289712,0.2675521821631879,0.8056342327873245,1.0,3/17,3.73%,ITPR2;ITPR1;TPCN1
prerank,I-SMAD binding (GO:0070411),0.5376359020665559,1.1947832624907357,0.2821969696969697,0.8038339863092163,1.0,3/13,4.77%,SMAD3;TGFBR1;SMAD6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.4778656783394519,1.192542479268623,0.2504317789291883,0.8043348212094129,1.0,9/28,14.68%,PRKAA2;LRRK2;MAP2K5;MAPKAPK3;AURKB;MAPK10;MAP2K1;MAP2K2;MAP2K6
prerank,metallocarboxypeptidase activity (GO:0004181),0.4862332774720695,1.1910856162051735,0.2580071174377224,0.8022903775678202,1.0,3/26,6.03%,AEBP1;CPA4;PEPD
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3954434739147917,1.188182476689915,0.20754716981132076,0.8054250280635764,1.0,11/75,8.99%,ME2;SORD;CRYL1;AKR1B10;LDHB;BDH1;DHDH;DHRS11;DHRS3;BDH2;LDHD
prerank,GTPase regulator activity (GO:0030695),0.3491066218858743,1.1849177211372732,0.15659679408138102,0.808821040968571,1.0,49/212,14.46%,RANBP3L;CPEB2;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;SRGAP2;ARHGAP18;SYDE2;ARHGAP9;ALS2;ALDH1A1;NPRL3;RGS16;TBC1D16;ASAP3;LRRK2;GMIP;ARHGAP26;ARRB1;GPS2;ASAP1;NPRL2;ARHGAP17;ARFGAP3;ELMOD3;DNM1L;OPHN1;WASL;GRTP1;RALGAPB;MTSS2;RANBP3;OCRL;PDE6D;RALBP1;RGPD1;GNB5;KRIT1;RIC8B;RAP1GAP;HACD3;DEPDC5;SGSM2;FLCN;LLGL2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.39037227881989206,-1.1836982064414192,0.19602977667493796,0.5860226122750627,1.0,14/35,22.70%,PEAK1;PTK2B;LYN;BMX;PTK2;TEC;FES;SYK;PKDCC;BTK;TXK;SLA;YES1;FYN
prerank,myosin binding (GO:0017022),-0.35913037017648763,-1.183590078828713,0.18696883852691218,0.5810561240947584,1.0,11/55,11.41%,MYRIP;GSN;STXBP5L;MOBP;SHROOM4;RAB3C;NKD2;MYOC;SHROOM1;CALD1;RAB27B
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.43451224886372763,-1.1833052613670079,0.2331002331002331,0.5766342783826045,1.0,5/20,11.31%,DLG2;MAGI3;CASK;MPP1;CMPK1
prerank,leak channel activity (GO:0022840),0.5097131097770861,1.1799075077536936,0.27079646017699116,0.8183052952401095,1.0,1/18,0.26%,KCNK2
prerank,pyridoxal phosphate binding (GO:0030170),0.4963501407968277,1.177559812759657,0.26654740608228983,0.8195294597241821,1.0,5/20,12.61%,PYGM;SRR;CTH;ABAT;ACCS
prerank,cytokine activity (GO:0005125),0.3634795327221549,1.1768840250666714,0.19363762102351315,0.8152569509996902,1.0,9/131,6.47%,WNT5B;BMP6;BMP7;WNT4;WNT6;IL18;IFNK;IL17D;IL12B
prerank,cholesterol transfer activity (GO:0120020),-0.46131189064920886,-1.1767598787307931,0.270509977827051,0.5877003617950363,1.0,6/16,12.10%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3297775500165081,1.1767321786041895,0.1386946386946387,0.8094419284789381,1.0,77/346,18.78%,RNF220;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;PRKN;TRIM63;RNF213;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;TTC3;RNF8;FBXW11;BCOR;RNF141;HUWE1;TRIP12;RNF217;BTRC;RNF19A;RNF34;UBR5;FBXO22;SH3RF1;UBE2M;RNF41;FBXW8;FBXO4;RNF13;CDC42;WWP2;CUL4A;FBXO10;TRIM62;ASB12;DDB2;PML;FBXO11;DTX3;DZIP3;UBE2H;RNF115;RMND5A;AMFR;RNF31;HECTD1;RNF146;BIRC6;BIRC3;MAEA;RNF19B;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;CDC34;RNF25;RNF20;TAF1;ARIH1;MIB2;ASB1;NHLRC3;RNF214
prerank,RNA methyltransferase activity (GO:0008173),0.501916092938555,1.1729877604362728,0.27992957746478875,0.8148030589312425,1.0,1/19,0.80%,TRMT9B
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5712903662572368,1.1702400760326361,0.3134920634920635,0.8168771314478137,1.0,3/10,6.76%,CACNA1D;CACNA1C;CACNB3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.48189192161839933,-1.1688547787813837,0.27912087912087913,0.6017414607254324,1.0,3/13,3.18%,PIP5K1B;PIP4K2A;PIK3C2B
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5049579015724808,1.1686751658577699,0.2817391304347826,0.815670272324677,1.0,7/17,15.44%,DPYD;BDH2;PTGR2;MECR;TM7SF2;LBR;DECR1
prerank,translation elongation factor activity (GO:0003746),-0.47149178014784493,-1.1627047338398415,0.27467811158798283,0.6132473824128604,1.0,10/14,37.79%,EEF1A1;EIF5A2;EEFSEC;EEF2;TUFM;EEF1A2;GTPBP2;GFM1;EEF1B2;GTPBP1
prerank,ephrin receptor activity (GO:0005003),-0.44485567055290026,-1.1585099591778307,0.24541284403669725,0.612862783822919,1.0,5/17,7.96%,EPHB1;EPHA5;EPHA6;EPHA7;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.44485567055290026,-1.1585099591778307,0.24541284403669725,0.612862783822919,1.0,5/17,7.96%,EPHB1;EPHA5;EPHA6;EPHA7;EPHB2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.49328925943814517,-1.1580610100755457,0.28964059196617337,0.6089304037537697,1.0,5/13,11.97%,RYR2;GSK3B;KCNQ1;PRKAR1B;PRKAR2B
prerank,leucine zipper domain binding (GO:0043522),0.5529087389107573,1.1564124864673486,0.3236514522821577,0.8465338028986965,1.0,1/10,0.75%,PAWR
prerank,platelet-derived growth factor binding (GO:0048407),0.5551571528232359,1.1563477700026399,0.31297709923664124,0.8404493215693213,1.0,3/11,8.18%,COL5A1;PDGFRB;COL1A2
prerank,phospholipase activity (GO:0004620),-0.3355867453159803,-1.1525967602296712,0.22023809523809523,0.6170070221582592,1.0,13/67,14.40%,PLCB4;PLCL1;PLA2G4A;PLCE1;MGLL;GDPD1;PDIA3;PLA2G12A;ENPP2;SMPDL3A;PITPNM3;PNPLA3;ABHD4
prerank,nucleotidase activity (GO:0008252),0.523094977046801,1.1514715307385002,0.29887218045112784,0.8493098870537252,1.0,7/15,18.54%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,copper ion binding (GO:0005507),0.41626673970431166,1.1511621166480523,0.28874388254486133,0.8441083608670239,1.0,5/42,6.50%,MOXD1;LACC1;SOD3;LOXL3;TP53
prerank,hexosyltransferase activity (GO:0016758),-0.3114518673439544,-1.1509524571631509,0.18770226537216828,0.6161239974973449,1.0,17/101,12.19%,TMTC2;CSGALNACT1;MGAT4C;GCNT2;CHSY3;FUT9;EXT1;MGAT4A;DPY19L1;B4GALT5;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5072209112372585,1.150300340944322,0.32452830188679244,0.8404826648068555,1.0,7/14,18.94%,RSAD2;NDUFS1;NFU1;ACO2;CIAO3;SDHB;ETFDH
prerank,endopeptidase inhibitor activity (GO:0004866),0.3678091906304929,1.1495555748203325,0.23462088698140202,0.8370103754606643,1.0,10/82,8.46%,ITIH2;TIMP3;TFPI;SERPIND1;RENBP;COL4A3;KNG1;SERPINE1;SERPINA9;HRG
prerank,MAP kinase kinase activity (GO:0004708),0.5174556162907746,1.1465019740141658,0.3309222423146474,0.8401283640044148,1.0,8/15,18.76%,LRRK2;MAP2K5;MAPKAPK3;MAPK10;MAP2K1;MAP2K2;MAP2K6;MAPK14
prerank,ribosome binding (GO:0043022),0.40628720817495567,1.1459537714714327,0.2961240310077519,0.8360591240355185,1.0,6/46,12.06%,CPEB2;CPEB4;CPEB3;YTHDF3;IGHMBP2;ETF1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4803729177423875,1.1455846809643881,0.29246935201401053,0.8312119293717909,1.0,1/22,0.33%,CPEB2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5422463356109232,1.1402543428774068,0.32122370936902483,0.8420229417311784,1.0,1/11,1.47%,NUDT4
prerank,Tat protein binding (GO:0030957),-0.5013465946130445,-1.1385491132047145,0.3084677419354839,0.6418422680802371,1.0,2/10,2.48%,ACTB;MDFIC
prerank,cardiolipin binding (GO:1901612),0.5499242597945811,1.1370969129967985,0.33925049309664695,0.8453824818880897,1.0,2/10,7.05%,GSDME;OPA1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.554763258494731,1.137096158687388,0.3531669865642994,0.8395522578750685,1.0,3/10,6.70%,RENBP;GALM;DSE
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.36964185880702355,-1.135394727155327,0.24331550802139038,0.6446933976299888,1.0,6/34,5.31%,CYTH3;ARAP2;MYO10;MYO1B;IQGAP1;ARAP3
prerank,phospholipase binding (GO:0043274),0.5197673872132061,1.132718265306988,0.343811394891945,0.8466485806364789,1.0,3/13,8.74%,PRKN;ARHGAP6;PDPK1
prerank,sterol transfer activity (GO:0120015),-0.4356031748066586,-1.1315297319333457,0.3080357142857143,0.6498598049676186,1.0,6/17,12.10%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,transaminase activity (GO:0008483),0.5375846341117257,1.1298964796596749,0.3393213572854291,0.8493337187110026,1.0,5/11,19.84%,BCAT2;GOT2;ABAT;GOT1;GOT1L1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4286127771342975,1.12444257973477,0.3136593591905565,0.8605807036943055,1.0,11/35,20.86%,TRMT9B;PTRH1;TARS2;DUS4L;PUS10;LCMT2;NT5C3A;DUS3L;DTWD2;DUS2;DUS1L
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3044630851644415,1.1230983085685666,0.18278427205100956,0.858953779887313,1.0,120/597,17.59%,HLF;MAF;THRB;SMAD3;OSR1;NFYC;CUX1;PKNOX2;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;GABPB1;GABPB2;HOXA1;ZNF568;ARID4A;NFAT5;SOX5;ELF1;NR6A1;GLI3;ARNT2;FOXC1;NFIB;MAFG;ATOH1;MBNL2;NFYB;CREB3L2;NHLH2;SMAD6;CUX2;BNC2;TEF;ESRRA;HOXB9;HOXB5;TP53;TBL1X;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;BCOR;ELF2;NR1D2;HOXC4;TBL1XR1;ZIC1;IRX1;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;SOX13;ASH2L;FOXC2;TCF7L2;TCF4;ABL1;PRDM5;NFATC3;RARG;ATF2;HNRNPL;SKOR1;MYBL2;TEAD1;HES6;HOXB2;BRD7;FOXA2;NR3C2;IRF1;KMT2D;KAT7;ZBTB48;FOXJ2;DHX33;MCM7;MCM2;BEND3;TBP;ORC3;ATF6B;NCOR1;ZBTB32;SNAI1;PER2;HOXA7;E2F4;NFKB1;TAF7;HOXB8;HSF2;MZF1;NKX2-1;TGIF2;RXRA;RFX2;PER3;CENPC;HSF4;KLF15;HIVEP1;SMAD4;MEF2D;TCF7L1;MBD4;POU1F1;ELF4;BARX2
prerank,transcription corepressor binding (GO:0001222),0.44741637488377317,1.122387102254019,0.31965811965811963,0.8554655618951658,1.0,9/27,17.01%,RORA;LCOR;USP11;PHF1;PER2;EHMT2;PER3;EHMT1;CTBP2
prerank,general transcription initiation factor binding (GO:0140296),-0.3926179721253492,-1.1216131673514362,0.2992874109263658,0.6704270365499615,1.0,12/25,29.04%,ESR1;AR;GTF2A2;YEATS2;TAF1B;HHEX;RUVBL2;RELA;DR1;THRA;DRAP1;AHR
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4452442666508808,-1.1189519467164395,0.3233404710920771,0.6722902224254548,1.0,6/15,19.85%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,titin binding (GO:0031432),0.5140932312552728,1.117487697516025,0.3643122676579926,0.8652769196261338,1.0,2/13,2.82%,ACTN2;TRIM63
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4661495044516637,-1.116127260058031,0.3416856492027335,0.6741318819974182,1.0,4/14,9.27%,MAL;APAF1;NOD1;ATP2A3
prerank,cAMP response element binding (GO:0035497),0.5234398977081427,1.1150303114533742,0.34790874524714827,0.8671427938875271,1.0,3/10,11.20%,CREB5;CREB3L2;ATF2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.48600891521989076,-1.1136607720722294,0.33405172413793105,0.6750918091362498,1.0,2/12,13.37%,CDK19;CDK8
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5213821439692993,1.1129272834386377,0.3523809523809524,0.8677623270060153,1.0,2/11,2.95%,SASH1;PPEF2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3869452777025764,1.1124809210263087,0.32153846153846155,0.8634263731587482,1.0,5/55,3.20%,CACNA1D;SLC24A3;ITPR2;ITPR1;MCU
prerank,vinculin binding (GO:0017166),-0.48221258720641463,-1.1122332729187967,0.33867735470941884,0.6738363581491139,1.0,3/11,6.69%,UTRN;ACTN1;CORO2B
prerank,SH2 domain binding (GO:0042169),0.4291379802980555,1.1119067998532386,0.33614864864864863,0.8596910951465101,1.0,5/31,6.84%,AFAP1;INPPL1;DAG1;SH3PXD2B;AFAP1L2
prerank,ATPase binding (GO:0051117),-0.3207301833979294,-1.1113040405401555,0.26047904191616766,0.6710045370128247,1.0,15/71,8.80%,PDE4D;CAV1;SLC2A13;ESR1;ATP6V0A1;ATP1B1;AR;NKD2;TRPC1;PSEN1;ATP6V0A4;PPP3CA;RDX;RALB;DNAJC10
prerank,voltage-gated calcium channel activity (GO:0005245),0.42031347712329403,1.1112287453077205,0.3127035830618892,0.8563451995810828,1.0,5/37,6.76%,CACNA1D;CACNA2D3;CACNG4;CACNA1C;CACNB3
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37169336140052384,1.1111512079877672,0.3020833333333333,0.85114686147861,1.0,15/71,9.28%,EYA1;PTPN13;EYA2;PTPN14;PTPN9;MTMR3;EYA4;TNS2;PTPN23;PTPRU;PTPN22;CDC14A;PTEN;PTPN21;CDC25A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.4090163607419546,-1.110723251183936,0.31695331695331697,0.6670946168251843,1.0,2/21,3.80%,GRIK2;GLRB
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.33674339148432186,-1.1100376725204226,0.26956521739130435,0.6637702801569704,1.0,16/53,13.21%,SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC38A6;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5;SLC17A6;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7
prerank,protein phosphatase binding (GO:0019903),-0.292288721981222,-1.1063896707506995,0.23333333333333334,0.6676675311513941,1.0,30/117,16.19%,PIK3R1;MAP3K5;PTPRT;IQGAP1;PPP1R16B;STAT3;GRIN3A;DAB2IP;MET;FOXO1;KCNQ1;PTK2;PPP1R16A;CEACAM1;FBXL2;MFHAS1;JAK1;FLT4;ERBB2;AKAP11;ATP2B4;MTMR9;CTNNB1;MAPT;SMG5;KIF3A;STRN4;MYO16;EIF2AK3;SKAP1
prerank,phosphatase activity (GO:0016791),0.3736664156171302,1.105386629589387,0.31458966565349544,0.8628919880528307,1.0,11/73,11.59%,ATP1A2;PPP1CB;CILP2;LHPP;HDDC2;PXYLP1;PTPN22;PRUNE1;DUSP10;OCRL;NOCT
prerank,syntaxin binding (GO:0019905),0.37625377239025143,1.1045098220151208,0.3118279569892473,0.8601833325496558,1.0,10/61,11.99%,SYT9;UNC13C;SYT12;STXBP4;LRRK2;STXBP2;VPS54;BLOC1S6;ABL1;VAMP1
prerank,N-acetyltransferase activity (GO:0008080),0.4667686329474273,1.1041707670618033,0.3612565445026178,0.8557997752468249,1.0,9/19,26.47%,NAA80;SAT1;SMARCE1;KAT2B;EP300;ESCO1;NAT1;AANAT;NAA50
prerank,symporter activity (GO:0015293),0.533774744524397,1.1039772743159963,0.3645418326693227,0.8510149194979147,1.0,2/10,6.86%,SLC5A5;SLC5A8
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4455609556149632,-1.1011731807849723,0.33796296296296297,0.6757359822559124,1.0,6/15,18.32%,PLA2G4A;PLEKHA5;JPH2;SESTD1;PHLDA3;PLA2G4E
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.48508431069690694,-1.101158248419552,0.36438923395445133,0.670767290950413,1.0,1/11,2.10%,HCN1
prerank,peptide hormone receptor binding (GO:0051428),-0.4805091838723953,-1.100584303259775,0.32397408207343414,0.6672874852032572,1.0,8/11,50.79%,PTHLH;GNRH1;VIP;UCN2;CCK;GPHB5;ADCYAP1;GHRH
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.32787175073705443,1.098815019434271,0.29325153374233126,0.8611120395438053,1.0,60/181,18.95%,SMAD3;PPARGC1A;PPARA;NCOR2;ARNT2;RERE;IFI27;NHLH2;CHD4;PIAS1;NCOA3;TEAD3;TP53;BCAS3;BHLHE41;SMARCD3;LDB1;LDB2;MEF2A;SMARCA4;RBL2;SPEN;CDK5RAP3;PARP9;SMARCE1;HDAC4;SIRT1;HDAC1;TCF7L2;ATN1;MKKS;RBL1;ATF2;RBBP8;WWP2;BBS10;HES6;TBP;SIN3A;TAF4;NCOR1;MIER3;CTDP1;FAF1;MTA2;PIAS3;HIF1AN;BBS2;RXRA;RB1;CREBBP;GTF2I;MED1;POU1F1;RNF25;KDM1A;CRY1;TAF1;MAPK14;PIAS4
prerank,epidermal growth factor receptor binding (GO:0005154),-0.39513888291052096,-1.0987794658198353,0.2935560859188544,0.6672417793331459,1.0,3/25,4.40%,HIP1;ERBB4;CCDC88A
prerank,ATP hydrolysis activity (GO:0140603),0.4070178369774578,1.096367449804534,0.34442595673876875,0.8631612101139333,1.0,6/41,8.11%,ABCA4;RNF213;MYO18A;DDX3X;CLPX;MYO19
prerank,gated channel activity (GO:0022836),-0.4550916309325445,-1.0951583714520996,0.37209302325581395,0.6713826283305085,1.0,4/14,19.05%,PIEZO2;PIEZO1;TMEM266;TMEM63A
prerank,ligand-gated calcium channel activity (GO:0099604),-0.40473774858056144,-1.0929547605182601,0.32894736842105265,0.671757970909196,1.0,9/19,19.38%,RYR2;GRIN2B;RYR3;GRIN2A;TRPM2;GRIN1;ITPR3;TRPA1;RASA3
prerank,nucleotidyltransferase activity (GO:0016779),0.45456801841639066,1.092438653913128,0.35526315789473684,0.8689179404260629,1.0,7/19,16.39%,DNTT;REV1;TUT4;TERT;TENT2;TENT4B;TUT7
prerank,kinase binding (GO:0019900),-0.24455850296041112,-1.0920056974883572,0.12121212121212122,0.6691645368601276,1.0,93/435,12.99%,UTRN;DLG2;FRMD5;GHR;PTPRJ;UNC5C;RHOBTB1;SLC12A7;CAV1;GSN;ACTB;PDE8A;ESR1;CADPS;TTC28;POLA1;PTPRK;NBEA;IQGAP1;RND3;STAT3;BCAR3;SLC12A2;CIT;CAV2;RPS6;ACSL3;ACVRL1;TFRC;HDAC7;ARHGEF7;HSP90AB1;PPP1R12A;PPP2R5A;GSK3B;DAB2IP;RPS19;TIAM1;CNKSR2;CALM1;PTPRC;FLNA;LAPTM4B;SNAP91;CALM2;RPS3;PLCG2;RHOB;DCX;CSPG4;CRK;DNM1;RPS7;SMAD1;EEF1A1;PTK2;WWC1;PEBP1;PTN;IRAK3;CEACAM1;BTG1;VDAC1;NSF;TRPV4;MYOM1;RHOH;ADD2;CDK5RAP2;ACTA2;TRIM14;BCAR1;CALM3;PKD1;SLC12A4;MSN;DUSP3;PIK3IP1;CNTLN;TRIM27;EIF4ENIF1;ATF4;CTNNB1;ILK;ADIPOR1;FAS;IKBKB;INKA2;EMP2;CDKN1A;MAPT;HIF1A;AXIN1
prerank,ankyrin binding (GO:0030506),-0.41247914893976667,-1.0916706724684884,0.3211845102505695,0.6652493180307547,1.0,6/19,13.54%,SLC8A1;SPTBN1;PTPRC;NRCAM;CDH1;SPTB
prerank,SUMO transferase activity (GO:0019789),0.47333711825852026,1.0911897253505407,0.366120218579235,0.8671058420929414,1.0,6/16,20.99%,PIAS1;HDAC4;NSMCE2;PIAS3;PIAS4;UBE2I
prerank,clathrin adaptor activity (GO:0035615),0.4793066719984388,1.0897940135220001,0.35535714285714287,0.8659392555020508,1.0,3/15,7.67%,DAB2;STON1;AP1G2
prerank,protein heterodimerization activity (GO:0046982),0.3220346094737014,1.0887198041661792,0.3112244897959184,0.8638717702686988,1.0,17/178,6.93%,ATP1A2;EPAS1;BMP6;TOP2B;NPAS3;ZHX2;ARNT2;ADRA2A;KRT1;BDKRB2;MIGA2;TLR4;TPM1;IL12B;TP53;MICU1;BHLHE41
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4930129480443547,1.0865606601549629,0.3772893772893773,0.8649281195115314,1.0,2/13,4.24%,AGPAT4;GPAT2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5297064043294668,1.0852025036713022,0.40804597701149425,0.8634442161102982,1.0,5/10,21.89%,ECHDC3;ECHDC1;EHHADH;HADHA;ECHS1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4997053501544045,1.084989052506368,0.3831417624521073,0.8590569142135703,1.0,4/12,16.57%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.48635098634274204,1.0840493674298044,0.3747747747747748,0.8568135248868994,1.0,5/14,16.81%,ALDH4A1;MTHFR;ALDH1L1;AASS;MTHFD1
prerank,disordered domain specific binding (GO:0097718),-0.381747664303645,-1.0814987895383696,0.3501199040767386,0.6856922782819844,1.0,6/23,10.44%,FN1;HSP90AB1;CALM1;CALM2;HSP90AA1;CALM3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5021093358893823,1.0800277342588611,0.39768339768339767,0.8632335240486808,1.0,4/11,16.57%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4687267706349295,1.0761422490023755,0.3788706739526412,0.869550252904045,1.0,1/16,0.19%,SLC13A3
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.49446266903873437,1.0750928349173905,0.38733705772811916,0.8676202871386048,1.0,2/12,5.76%,GNAT2;RHO
prerank,mRNA binding (GO:0003729),0.3104561245200388,1.0747702778247328,0.32391048292108365,0.8635986850908604,1.0,65/249,18.66%,CPEB2;CELF2;SRRM2;DDX5;RBM47;CPEB4;RBMS2;LARP4B;SNRNP70;PCBP2;HNRNPR;IGF2BP1;SRSF5;DDX3X;ZC3H12B;TP53;ZCCHC13;CLUH;SNIP1;HNRNPA2B1;PABPC4L;SAMD4A;RBM15;LARP1;CPEB3;IGF2BP2;NOVA1;CSDC2;RBMS1;LSM14A;YTHDF3;LUC7L3;SCAF8;NUP98;HNRNPL;MRPS7;NOCT;DDX6;ETF1;DCP1A;RBPMS2;DHX33;ZC3H12C;HNRNPC;RSL1D1;PURB;NYNRIN;PABPC5;ZFP36L1;FUBP3;RBM4;SLC4A1AP;DAZAP1;HNRNPM;MARF1;GRSF1;CRYZ;RBMS3;SRSF1;EIF4G1;BOLL;RNF20;LARP4;SRBD1;PCF11
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4261681834404196,-1.0725973111646991,0.3752577319587629,0.7031285381698523,1.0,3/16,4.70%,SLC26A7;SLC26A2;SLC1A1
prerank,TBP-class protein binding (GO:0017025),-0.39174828250201316,-1.0706527263136338,0.37727272727272726,0.7031049684457789,1.0,10/21,29.04%,ESR1;GTF2A2;YEATS2;TAF1B;HHEX;RUVBL2;DR1;THRA;DRAP1;AHR
prerank,metallopeptidase activity (GO:0008237),0.33438397820520466,1.0705661617697815,0.3486750348675035,0.8704453104312909,1.0,24/113,15.78%,ADAM12;ACE;ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;METAP2;ADAMTS9;ADAM30;MMP19;RCE1;CHMP1A;BMP1;ADAM28;MMP14;ADAM18;ADAM17;ERAP1;PITRM1;ADAMTS7;ZMPSTE24;NRDC;ANPEP
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5162882896117054,1.068180712263718,0.3988439306358382,0.8719275818998191,1.0,2/10,3.52%,CFLAR;CASP3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.40951565798064066,1.0679465328681133,0.3735144312393888,0.8676333334862995,1.0,9/29,18.76%,ACE;MAPKAPK3;CDK5RAP3;SIRT1;ABL1;DUSP10;DUSP2;DUSP4;MAPK14
prerank,acyl-CoA hydrolase activity (GO:0047617),0.44956179478301417,1.0668961211154933,0.39162112932604737,0.8658859093964386,1.0,6/17,17.08%,ACSBG2;PLA2G6;ACOT11;ACOT8;THEM4;ACOT12
prerank,histone deacetylase activity (GO:0004407),0.4565787990762849,1.0643007027029072,0.3799621928166352,0.8685135638581893,1.0,6/19,14.58%,HDAC8;SIRT3;HDAC4;SIRT1;HDAC1;MIER3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.35387727567651905,1.0630789835715677,0.36323529411764705,0.8670471450655619,1.0,7/72,2.78%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4
prerank,chemokine receptor binding (GO:0042379),-0.3561019669057251,-1.0616991453638482,0.37468354430379747,0.7208993701705014,1.0,23/35,47.13%,CXCL12;CXCL16;CX3CR1;CCL13;CCL19;CXCL10;CCL2;CCL28;CCRL2;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;CCL14;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3166403684007215,1.0606115081641379,0.3403205918618989,0.8692474236858708,1.0,57/189,19.49%,SMAD3;FHL2;ZMYND8;PPARA;CXXC5;RERE;IFI27;NFYB;NHLH2;CHD4;PIAS1;TEAD3;TP53;SIK1;BHLHE41;LDB1;LDB2;MEF2A;RBL2;SPEN;HDAC4;SIRT1;TLE1;HDAC1;TCF7L2;ATN1;MKKS;RBL1;PRDM5;ATF2;RBBP8;WWP2;CBX5;BBS10;HES6;TBP;SIN3A;TLE2;NCOR1;MIER3;PURB;MTA2;PIAS3;BBS2;RB1;CREBBP;GTF2I;MEF2D;POU1F1;KDM1A;CRTC1;TAF1;NBN;PIAS4;YAP1;MTA1;RUNX1T1
prerank,peptidoglycan binding (GO:0042834),-0.482892660954699,-1.0594247593547241,0.38865546218487396,0.7219916702158721,1.0,3/10,17.24%,NOD1;PGLYRP1;NOD2
prerank,double-stranded RNA binding (GO:0003725),-0.29849473256313086,-1.0591356110483205,0.33432835820895523,0.7178363765048958,1.0,20/70,19.42%,MBNL1;ACTN1;LRRFIP1;RFTN1;ADARB1;ADARB2;TFRC;HSP90AB1;MSN;DROSHA;FXR1;STAU2;VIM;STRBP;MTDH;DHX15;DHX9;EIF4A1;SLC3A2;TLR7
prerank,aspartic-type peptidase activity (GO:0070001),0.5059745760776067,1.056378424734708,0.38549618320610685,0.8767460227380018,1.0,1/10,1.47%,BACE2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4294256591748801,-1.0515852163478543,0.4175152749490835,0.7325953282629296,1.0,2/15,2.84%,SLC26A7;SLC26A2
prerank,hydro-lyase activity (GO:0016836),0.3854346713927356,1.0488423411527523,0.4062992125984252,0.8931494010498547,1.0,14/41,22.46%,ECHDC3;GMDS;HACD4;HACD1;UROC1;ACO2;HACD3;ECHDC1;EHHADH;L3HYPDH;HADHA;ECHS1;CBS;PCBD1
prerank,voltage-gated potassium channel activity (GO:0005249),0.34872394488744535,1.0468338371033332,0.4071942446043165,0.8939721559350655,1.0,6/80,1.93%,KCNK2;KCNT1;KCNJ13;KCND3;KCNA5;LRRC38
prerank,small GTPase binding (GO:0031267),0.3134388918125298,1.0464488499733038,0.37547892720306514,0.8903925729288118,1.0,54/170,19.16%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;NOX1;RAB34;BRAF;RIN3;EXOC2;TRIOBP;RABGGTA;DNM1L;DOCK7;CYRIB;RNF41;FGD1;MTSS2;OCRL;PDE6D;RALBP1;MYO1C;MAPKAP1;RGP1;ANKRD27;RAP1GAP;GOLGA4;SGSM2;RUSC2;MICALL1;EXOC4;SPHK2;RAB29;ARFIP2;GOLGA5;TMEM127;KCTD13;SGSM3;OPTN;RABGEF1;PEX5;RANBP9;PAK2;TBC1D7;EVI5;RTKN;ARHGAP1;USP33;UNC13D
prerank,Notch binding (GO:0005112),0.43605851330834156,1.0462576148808909,0.41379310344827586,0.8861525048111184,1.0,4/22,3.66%,SNED1;NCOR2;AAK1;DTX1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.39388622058542505,1.043171984491973,0.41056218057921634,0.8899292620433239,1.0,13/34,22.70%,SMYD3;KMT5B;SETD7;NSD3;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E;SETD3;N6AMT1;CAMKMT;EEF1AKMT1
prerank,protein kinase C binding (GO:0005080),0.38122971778308945,1.0424195847865614,0.3948220064724919,0.8874011321081826,1.0,10/43,13.89%,PARD6G;TOP2B;GRK5;PRKCB;DACT2;PICK1;ABL1;ITGAV;ADCY6;PRKCSH
prerank,GTPase inhibitor activity (GO:0005095),0.4812145106210077,1.042389205588646,0.4169811320754717,0.8828205345704262,1.0,2/13,5.71%,CPEB2;GPS2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.46492952423011846,-1.0414501629199864,0.42369477911646586,0.7534377633808943,1.0,4/10,14.21%,ANKRD13A;DNAJC2;LAPTM5;FAAP20
prerank,phosphatidylinositol kinase activity (GO:0052742),0.46560350681255813,1.0409888130509495,0.44095940959409596,0.8818454060415939,1.0,7/15,18.63%,PI4KA;ATM;PIK3CA;PIKFYVE;PIK3R3;PI4K2B;PI4KB
prerank,triglyceride lipase activity (GO:0004806),0.43868300550311967,1.0398179712581355,0.42226148409893993,0.8805349137793995,1.0,3/20,8.93%,CEL;PNLIP;DDHD2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4814567215301623,1.03859056265776,0.42084942084942084,0.8792432097942089,1.0,2/11,1.46%,ITPR2;ITPR1
prerank,RNA polymerase II complex binding (GO:0000993),0.39494994519551546,1.0385617401327287,0.40847457627118644,0.8748198335152889,1.0,6/32,12.71%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,kinase activity (GO:0016301),0.33369499922385804,1.0376765901707226,0.4146685472496474,0.872735635747475,1.0,28/109,18.84%,NADK2;EPHA4;SPHK1;PI4KA;LRRK2;GK5;TKFC;GK;PANK1;PIK3CA;COQ8B;ITPKB;DCAKD;PPIP5K2;ABL1;CSNK2A1;COQ8A;SPHK2;CERK;FN3K;FCSK;SCYL3;NADK;IP6K3;PKN2;TAF1;PI4KB;CHKA
prerank,protein kinase binding (GO:0019901),0.2823437565695557,1.036200280080749,0.3907793633369923,0.8721599213845527,1.0,65/480,11.35%,PRKAG2;MAPK4;PARD6G;SMAD3;ACE;ANK2;OXSR1;ERRFI1;KIF13B;SASH1;DLG1;TOP2B;KCNA5;RHOBTB2;PRKN;EPHA4;RHOD;GRK5;CCNA2;PRKAG3;TOM1L2;PPEF2;CEP250;PPP1CB;SUFU;NISCH;ADRA2A;TPRKB;EZR;NBEAL1;PRKCB;DACT2;GYS1;FZD5;PTPN23;EXOC2;TRIB2;PDGFRB;TP53;SIK1;CACUL1;RICTOR;CCND3;MAPKAPK3;CDK5RAP3;GPRC5B;CDH5;MVP;CDC25A;SIRT1;PICK1;MAVS;TCF7L2;BECN1;NOX4;IRGM;ABL1;CASS4;DUSP10;JTB;CENPJ;RNF13;ATF2;TRIB1;CDC42
prerank,PDZ domain binding (GO:0030165),0.35425905294633,1.036099350949259,0.4165366614664587,0.8679470102271055,1.0,11/61,7.92%,TGFBR3;ARHGAP29;PRKN;ARHGEF16;CXXC4;FZD8;SYNJ2;PLEKHA2;SLC22A5;SRR;PTEN
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3639746048015341,-1.0349778343296905,0.40232558139534885,0.7649173304219085,1.0,5/26,12.19%,CSGALNACT1;CHSY3;B3GALT1;B3GALNT1;B3GALT5
prerank,cholesterol binding (GO:0015485),-0.31735577254355163,-1.0324273360977438,0.38920454545454547,0.7663786956792521,1.0,13/47,12.20%,CAV1;OSBPL6;PROM1;ABCG1;PTCH1;NPC2;APOD;STARD5;VDAC1;OSBP2;STARD3NL;STARD4;ERLIN1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3473495218875593,1.0319906343207605,0.4094488188976378,0.8741683106101181,1.0,13/69,16.30%,LPGAT1;SPHK1;MOGAT3;ASPG;CERS6;CERS5;KAT6B;ZDHHC18;ZDHHC1;PORCN;KAT2B;NAA16;CREBBP
prerank,cation channel activity (GO:0005261),0.3365419554162803,1.031848310281921,0.406993006993007,0.8701492804932921,1.0,5/94,3.20%,TRPM3;CACNA1D;SLC24A3;TRPM6;MCU
prerank,beta-tubulin binding (GO:0048487),0.40206132965719993,1.031536339963712,0.42439862542955326,0.8666026564406825,1.0,4/31,8.59%,GJB6;EML4;BCAS3;HTT
prerank,aspartic-type endopeptidase activity (GO:0004190),0.48639759657330606,1.030131657291256,0.43907156673114117,0.866026768817489,1.0,1/12,1.47%,BACE2
prerank,receptor ligand activity (GO:0048018),0.29455797797863364,1.0301013000231445,0.4007398273736128,0.8618041956460419,1.0,25/245,10.32%,FGF1;WNT5B;BMP6;BMP7;WNT4;IGF1;WNT6;IL18;METRNL;EDA;DPP4;TNFSF13;SEMA3B;F2;IFNK;IL17D;IL12B;OSGIN2;GDNF;NRG1;APLN;NBL1;HBEGF;CCL25;SLURP1
prerank,iron ion binding (GO:0005506),0.3638963227316188,1.0296556975010538,0.4393700787401575,0.8586531345795488,1.0,10/48,15.71%,KDM7A;TET2;SCD5;JMJD6;CYP2R1;NFU1;ACO2;PHF2;TET1;HIF1AN
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.46665359458697186,1.0292210414948157,0.4273204903677758,0.8556709284364772,1.0,2/14,1.80%,KCND3;KCNA5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4211355388879491,1.0282888993835713,0.42936802973977695,0.85394361325251,1.0,2/22,2.72%,DUSP29;MTMR3
prerank,chemokine activity (GO:0008009),-0.35242682890967947,-1.0279085554473806,0.41818181818181815,0.773469118566994,1.0,21/31,47.13%,CXCL12;CXCL16;CCL13;CCL19;CXCL10;CCL2;CCL28;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;CCL14;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3059425226241224,1.026624373383583,0.43703703703703706,0.8541409069465059,1.0,45/188,16.98%,SMAD3;NFYC;ZBTB20;GABPB1;GABPB2;ZNF568;ARID4A;SOX5;FOXC1;NFYB;CREB3L2;SMAD6;BNC2;TP53;TBL1X;SOX12;BCOR;TBL1XR1;CALCOCO1;HDAC4;GLI1;TCF7;SOX13;ASH2L;FOXC2;TCF7L2;PRDM5;HNRNPL;BRD7;FOXA2;IRF1;KMT2D;ZBTB48;TBP;ATF6B;NCOR1;PER2;NFKB1;TAF7;MZF1;NKX2-1;RXRA;PER3;KLF15;SMAD4
prerank,histone methyltransferase activity (GO:0042054),0.3942513950422952,1.0212726915851604,0.43986254295532645,0.864023637947591,1.0,10/32,17.67%,SMYD3;KMT5B;SETD7;NSD3;KMT2C;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.38074333643044556,-1.0209726968015957,0.45265588914549654,0.7862598651033328,1.0,5/21,16.78%,GRM5;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,chemokine binding (GO:0019956),0.39533917743427827,1.0195149089939035,0.4295652173913043,0.8647891285833852,1.0,3/30,3.72%,CCR9;ACKR2;PDPN
prerank,gap junction channel activity (GO:0005243),0.4207816230724413,1.0194896602565202,0.4446397188049209,0.8607042843428452,1.0,1/22,0.56%,GJB6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4580094272619576,1.0191332438733458,0.4349514563106796,0.8576634963181076,1.0,2/13,2.89%,SLC38A3;SLC7A2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.40547078637264733,1.0152811909754984,0.44276094276094274,0.8637121986385551,1.0,9/27,23.44%,POLR2A;POLR2D;TERT;TENT2;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,calcium:sodium antiporter activity (GO:0005432),0.49098565280106843,1.013499595689651,0.444022770398482,0.8642276507361407,1.0,2/10,1.99%,SLC24A3;SLC8A3
prerank,wide pore channel activity (GO:0022829),0.4163152112820478,1.0132833116764088,0.44173913043478263,0.860821469771888,1.0,1/23,0.56%,GJB6
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3863255573717227,1.0117230838205087,0.4324786324786325,0.8606551571166013,1.0,9/34,15.16%,FAM20A;ALS2;DDX3X;RICTOR;CCNT2;IRGM;MAP2K1;MAP2K2;STK4
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.36725139420758335,1.0116088504760936,0.432475884244373,0.8569092420209552,1.0,5/38,8.46%,TFPI;SERPIND1;SERPINE1;SERPINA9;HRG
prerank,transition metal ion binding (GO:0046914),0.2794863543337355,1.0109653545920394,0.4459308807134894,0.8545521756982334,1.0,57/397,12.41%,KDM7A;SMAD3;ACE;UPB1;MOXD1;SORD;ZMYND8;KMT2A;PRKN;LACC1;MPPED2;NAPEPLD;GLI2;LARGE1;CXXC5;CXXC4;SOD3;LOXL3;NAALADL1;CHD4;FBXL19;NSD1;TET2;BBOX1;SOD2;B4GALT1;BAZ1B;TP53;ENPP3;SIRT5;KNG1;SCD5;PLSCR1;RNF8;SAMHD1;KDM2B;ADAM30;KDM2A;SIRT3;HRG;JMJD6;CYP2R1;HDAC4;TAB2;NPEPPS;CHMP1A;PTGR2;DHH;ABL1;ZKSCAN5;FNTB;DHX58;NFU1;PHF5A;ACO2;ZMYM2;LARGE2
prerank,fibroblast growth factor binding (GO:0017134),0.4215224195781959,1.0097561472059529,0.4426807760141093,0.8537963595334469,1.0,6/21,11.95%,FGFR2;KL;FGFR1;FIBP;KLB;ITGAV
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4809689136069033,1.0064033460286252,0.4637404580152672,0.8584928243379523,1.0,2/11,3.52%,CFLAR;CASP3
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.29174533561202876,-1.0051230786219134,0.43977591036414565,0.8232272925456716,1.0,13/70,12.19%,CSGALNACT1;MGAT4C;GCNT2;CHSY3;EXT1;MGAT4A;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,cation:chloride symporter activity (GO:0015377),0.4864497745273836,1.001350607564911,0.4485294117647059,0.8671348826261243,1.0,1/10,0.37%,SLC6A1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.42847768163307753,-1.0008716986759272,0.47045951859956237,0.8295895963519675,1.0,4/12,7.77%,PIK3R1;GNAS;SOCS2;YWHAG
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2645540024956165,-0.9954720094153626,0.44528301886792454,0.8384916325165946,1.0,13/100,6.44%,HIP1;CYTH3;ARAP2;MYO10;MYO1B;CERT1;PLA2G4A;IQGAP1;CLVS1;ARAP3;DAB2IP;LAPTM4B;PLEKHA5
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4075472383675286,-0.9938521456041278,0.468682505399568,0.8374750701607347,1.0,5/14,8.46%,SPOCK2;SPOCK3;NGF;TIMP2;SPOCK1
prerank,serine-type endopeptidase activity (GO:0004252),0.3285481532475271,0.9922433457179533,0.460431654676259,0.8862798958518376,1.0,6/80,5.34%,CORIN;KLK2;F11;DPP4;CTSH;F2
prerank,ion channel inhibitor activity (GO:0008200),0.3646387567069629,0.9900285562143777,0.45789473684210524,0.888100376258144,1.0,3/35,3.86%,WNK4;ITPR1;NEDD4
prerank,alpha-tubulin binding (GO:0043014),-0.331129974615368,-0.9889608185002159,0.468384074941452,0.844863918004359,1.0,12/31,18.83%,TTLL7;DIP2B;TRPV4;PACRG;SETD2;TRIM36;SNCA;CDK5R1;ARL8B;EFHC2;SPAST;TBCE
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.43704208977142056,0.9889465297728735,0.4724689165186501,0.8868663585484368,1.0,2/15,4.24%,AGPAT4;GPAT2
prerank,ATP binding (GO:0005524),0.2859233856543612,0.9889386714676103,0.49695493300852617,0.8829164238357707,1.0,42/266,15.28%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;NUAK2;CLPX;CDC42BPG;SIK1;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;ABCC6;BRSK1;SRPK2;ABL1;TRIB1;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;CAD;ATP5F1D;SYN3;STK17B;ACVR1B;STK4;CARS2
prerank,cation transmembrane transporter activity (GO:0008324),0.3528763692457436,0.9874052591264392,0.4605873261205564,0.8829101858991403,1.0,7/48,7.86%,SLC41A1;SLC38A3;SLC7A2;SFXN2;SLC6A9;SLC25A2;SLC38A1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.33926591350872304,-0.985635548413751,0.48299319727891155,0.8485767243005816,1.0,9/30,14.18%,CST3;GAS6;SPOCK1;RPS6KA3;SERPINB9;SNCA;RPS6KA1;CARD16;MT3
prerank,protein serine/threonine kinase activity (GO:0004674),0.274997066018849,0.9830443551259859,0.5209302325581395,0.8895826862610349,1.0,62/335,15.42%,MAPK4;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;STK32B;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;SMG1;PRKCB;IKBKE;ATM;CAMK1;BRAF;CLK4;NUAK2;CDC42BPG;SIK1;EIF2AK2;CPNE3;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;RIPK2;PIKFYVE;RIPK1;MKNK1;BRSK1;AURKB;SRPK2;DYRK1A;MYLK3;ARAF;PRKDC;MYLK;MAPK6;CSNK2A2;CSNK2A1;PRKCA;HIPK3;MAPK10;MAP3K1;PRKCI;RPS6KC1;WNK1;BMP2K;MAP2K1;GRK3;ACVR2B;STK17B;CLK1;ACVR1B;STK4;MAPK9
prerank,phospholipase A2 activity (GO:0004623),-0.3546980059478376,-0.980981614197636,0.45647058823529413,0.855971315848242,1.0,6/26,23.28%,PLA2G4A;PLA2G12A;PNPLA3;PLA2G4E;PLA2G15;PLA2G4F
prerank,phospholipase activator activity (GO:0016004),0.45881190555309326,0.9806358079716545,0.46771037181996084,0.8915083892925749,1.0,2/10,8.74%,ARHGAP6;PDPK1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3777864438760385,0.9803782559345391,0.472636815920398,0.8881522498195434,1.0,6/29,12.14%,SLC13A3;SLC26A3;SLC19A1;SLC26A1;SLC25A12;SLC25A11
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.41142158404214013,0.9800115438320535,0.4875,0.8851209240559266,1.0,3/20,8.10%,SLC30A10;SLC30A2;SLC39A13
prerank,zinc ion binding (GO:0008270),0.27803201970502867,0.9790648887763473,0.522248243559719,0.883652332700998,1.0,37/293,10.06%,KDM7A;SMAD3;ACE;UPB1;SORD;ZMYND8;KMT2A;PRKN;NAPEPLD;GLI2;CXXC5;CXXC4;NAALADL1;CHD4;FBXL19;NSD1;TET2;BBOX1;BAZ1B;TP53;ENPP3;SIRT5;KNG1;PLSCR1;RNF8;SAMHD1;KDM2B;ADAM30;KDM2A;SIRT3;HRG;HDAC4;TAB2;NPEPPS;CHMP1A;PTGR2;DHH
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.37285427960264544,-0.9788600223020728,0.4989010989010989,0.8563694842274617,1.0,6/18,19.85%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,phosphatidylinositol binding (GO:0035091),0.3157193150779192,0.9784010567416731,0.4677871148459384,0.8814186107367942,1.0,6/91,1.86%,APPL2;TULP3;ITPR2;PICALM;ITPR1;PARD3B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4032251363323731,0.9771737700530326,0.49914529914529915,0.88057924276446,1.0,7/24,17.97%,ITPKB;AK4;AK3;PPIP5K2;NME6;AK8;IP6K3
prerank,calcium channel activity (GO:0005262),0.3196132029713452,0.9767089800414418,0.5189340813464236,0.8777844629616871,1.0,9/84,8.36%,CACNA1D;SLC24A3;CACNA2D3;CACNG4;MCU;CACNA1C;CACNB3;TRPM5;ANXA9
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3943742922270357,-0.9735469097960504,0.49452954048140046,0.8654198146601145,1.0,6/14,15.38%,SLC1A2;SLC1A1;SLC25A13;SLC17A6;SLC38A7;SLC1A6
prerank,protein homodimerization activity (GO:0042803),0.2647262744714154,0.9732291200751183,0.5853920515574651,0.8818987546077119,1.0,64/590,9.89%,NADK2;MAPK4;SMAD3;APPL2;UPB1;DUSP29;TPD52L1;PAXX;KIT;CPQ;MTUS2;KMT2A;ST6GAL1;FGFR2;SRGAP2;ZHX2;SNX6;ALS2;CRYL1;NPR3;NR2F2;FGFR1;BMPR1A;NR6A1;PGRMC1;ADRA2A;DPYD;LRRK2;PEX11A;ZBTB38;NACC2;DPP4;FOXP2;NAALADL1;LHPP;MIGA2;TPM1;IL17D;GBP3;ZNF318;GALM;BHLHE41;LDB1;PANK1;RNF8;GBP2;PON3;SRR;PEX11B;IDH1;CLN6;SLC39A13;TERT;GDNF;KLHL7;SLC51A;CYP2R1;DNM1L;SSBP1;RIPK2;CBY1;BLOC1S6;RIPK1;CHMP1A
prerank,GTP binding (GO:0005525),-0.24455216090449763,-0.9729968028087695,0.5252100840336135,0.8617728281796049,1.0,59/172,25.51%,RHOBTB1;RHOJ;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;GCH1;RASL12;RAB27A;RHOB;GNAI1;RERG;EEF1A1;RALB;TUBA1A;MFHAS1;GLUD1;RAP2A;RHOH;GBP4;TUBB4A;ARL5A;ARL1;RAB27B;ARL5B;ATL2;MTG2;RAB38;RAB6A;RAB32;TUBB2B;RRAS;ARF5;ARF6;RAB39A;ARL8B;RHOBTB3;TUBB3;ATL3;RHEB;RAN;TUBA4A;MMAA;PIP4K2B;RND2;RAC3;GNL2;GEM;RAB14;TUBA1B;RHOC;RND1;TUBA1C;TUBG2;RNF112;ARF3;RAB1B
prerank,G protein-coupled receptor activity (GO:0004930),-0.23450268925980963,-0.9725282159154999,0.5,0.8577466757769734,1.0,55/239,23.19%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;GRM5;ADGRG6;GRM3;ADRA1B;ADGRE5;GRM8;RORB;XPR1;PDGFRL;AGTR1;GRM1;S1PR1;GPR156;GABBR2;P2RY12;LGR5;PTH1R;CYSLTR1;HCRTR2;CYSLTR2;GPR63;CMKLR1;ADGRA1;ADGRB1;GPR26;ADGRG1;P2RY1;HRH1;GPR34;APLNR;VIPR2;ADGRD1;CX3CR1;S1PR3;C3AR1;GPR45;PAX8;ADGRG2;GPR176;S1PR2;ADCYAP1R1;ADGRE1;GRM4;DRD2;P2RY14;MC5R;LANCL1;CXCR4;LHCGR;GPR37L1
prerank,ferrous iron binding (GO:0008198),-0.3494026293307536,-0.9714000443504617,0.5091743119266054,0.8557664183082907,1.0,7/21,20.31%,FTH1;FTL;SNCA;EGLN2;ISCU;EGLN3;ALKBH3
prerank,cGMP binding (GO:0030553),0.4515774605729711,0.9707012118110296,0.4779270633397313,0.8840148262723363,1.0,1/11,0.72%,PDE5A
prerank,CXCR chemokine receptor binding (GO:0045236),-0.42637330780026955,-0.9702663716694532,0.4864864864864865,0.85375022832702,1.0,6/11,37.01%,CXCL12;CXCL10;CXCL5;CXCL1;PF4;PPBP
prerank,lipase activator activity (GO:0060229),0.46432872233521016,0.9682870225487139,0.4908722109533469,0.8858305905446522,1.0,2/10,8.74%,ARHGAP6;PDPK1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.44610284785124965,0.9663536843189684,0.5127272727272727,0.8867237738669935,1.0,2/11,12.28%,SLC5A3;SLC5A11
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.31077490497887583,0.9640006831774224,0.5327635327635327,0.8885085439237965,1.0,12/91,9.26%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4;TTPAL;SH3PXD2B;WIPI1;ANXA9;PLCD1
prerank,translation initiation factor activity (GO:0003743),-0.3132763941545181,-0.9633533152331458,0.5131578947368421,0.8673296319447653,1.0,10/36,20.88%,EIF3M;EIF3F;EIF2B3;EIF3B;EIF1;EIF4E;EIF4A1;EIF3L;COPS5;EIF3D
prerank,ion gated channel activity (GO:0022839),-0.34513097834047624,-0.9630141645904938,0.5153846153846153,0.8631122233762367,1.0,8/24,15.40%,KCNT2;ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.27758286536363985,0.9614196180828429,0.5443499392466585,0.8909371556533241,1.0,36/254,13.63%,HLF;SMAD3;TFDP2;NFYC;PPARA;CREBRF;HOXA1;NFAT5;ELF1;MITF;FOXC1;NFIB;HOXB3;VEZF1;NFYB;RREB1;MEIS1;TP53;SOX12;SMARCD3;PLSCR1;MEF2A;HOXC4;TFDP1;NR2C2;FOXC2;TCF4;MYBL1;NFATC3;ATF2;MYBL2;HOXB2;IRF1;FOXJ2;NFIA;ATF6B
prerank,adrenergic receptor binding (GO:0031690),-0.3857778174486661,-0.9607657639892685,0.5248868778280543,0.8641305536782458,1.0,2/16,1.55%,PDE4D;GNAS
prerank,poly(A) binding (GO:0008143),0.40483836347120233,0.9603980147137084,0.5070175438596491,0.8896402570847811,1.0,9/21,18.46%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;PABPC5;HNRNPDL;RBMS3;LARP4
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.4026781958750927,-0.9594513574035829,0.5032679738562091,0.8623286241620046,1.0,1/12,1.49%,ENTPD1
prerank,double-stranded DNA binding (GO:0003690),0.2622526373136155,0.9594293910057781,0.5962800875273523,0.8881992049264723,1.0,69/531,12.98%,HLF;MAF;THRB;OSR1;CUX1;PKNOX2;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;HOXA1;NFAT5;ELF1;NR6A1;GLI3;ARNT2;NFIB;MAFG;ATOH1;MBNL2;NHLH2;CUX2;TEF;ESRRA;HOXB9;HOXB5;CAMTA2;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;ELF2;FBH1;NR1D2;HOXC4;ZIC1;IRX1;TEAD2;KLF3;ZBTB26;RBMS1;ZIC4;TCF7;NR2C2;DDX60;FOXC2;TCF4;ABL1;MAU2;NFATC3;RARG;ATF2;RBBP8;PRKDC;MSH3;SKOR1;MYBL2;TEAD1;HES6;HOXB2;FOXA2;RAD50;NR3C2;PNKP;TDG;ZBTB48;FOXJ2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.44787374466426944,0.9582436406527858,0.5251396648044693,0.8874207501230958,1.0,4/12,7.33%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,hormone activity (GO:0005179),0.3343615236159601,0.956720610209192,0.5133858267716536,0.8873589815258707,1.0,9/54,17.49%,IGF1;METRNL;APLN;AGRP;SPX;CCL25;NPFF;INHA;NMB
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.34312845810855896,-0.9557680966680815,0.512987012987013,0.8671298188732128,1.0,5/24,12.22%,CAMK2D;PTK2B;EEF2K;CAMK4;DAPK1
prerank,RNA stem-loop binding (GO:0035613),0.4510662659330861,0.9545135381240836,0.5113636363636364,0.8888695654116762,1.0,2/12,8.31%,DDX3X;CPEB3
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4051255058090521,-0.9538012968337655,0.5536842105263158,0.8671144982841328,1.0,4/12,13.21%,SLC6A6;SLC1A4;SLC38A5;SLC38A7
prerank,protein phosphatase 1 binding (GO:0008157),0.40023997598442984,0.9534543359920438,0.5330948121645797,0.8879331552248246,1.0,3/21,10.15%,SH3RF2;PPP1R3B;PHACTR4
prerank,hyaluronic acid binding (GO:0005540),-0.4160351745708279,-0.9511754940437576,0.5445344129554656,0.8686885521709253,1.0,3/10,9.92%,CEMIP;LAYN;CD44
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4089129537256302,-0.9510543465773,0.5359477124183006,0.8640155245570187,1.0,5/12,21.18%,APAF1;NOD1;ATP2A3;RPS27L;PYCARD
prerank,histone deacetylase binding (GO:0042826),0.3076648551611317,0.9505006692157452,0.5431400282885431,0.8911973128841599,1.0,15/88,9.55%,TOP2B;PRKN;NCOR2;GLI3;NACC2;CHD4;LCOR;TP53;CAMTA2;BHLHE41;NIPBL;BCOR;MEF2A;HDAC4;HDAC1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.34373443134235765,-0.9487578184333367,0.5590361445783133,0.8650334802043197,1.0,8/24,15.39%,KCNJ3;KCNJ2;KCNN2;ABCC9;KCNK1;KCNJ8;KCNJ6;KCNJ12
prerank,N-methyltransferase activity (GO:0008170),0.40064313076376534,0.9487048155320413,0.5277280858676208,0.8917218369430895,1.0,9/20,27.48%,HNMT;ZCCHC4;SETD3;GNMT;FDXACB1;N6AMT1;TRMT1L;METTL5;PEMT
prerank,protein phosphatase activator activity (GO:0072542),-0.394905044323339,-0.9466035767645864,0.548,0.8658481291914706,1.0,4/13,10.44%,PPP2R5A;CALM1;CALM2;CALM3
prerank,phosphatidic acid binding (GO:0070300),-0.34868672606256745,-0.9442083015139724,0.5365296803652968,0.8676012441406663,1.0,6/19,14.65%,MARK1;PITPNC1;PLTP;RAPGEF6;JPH2;SESTD1
prerank,phosphatase binding (GO:0019902),0.30114879409649653,0.9437976113977747,0.5563380281690141,0.8995793233415814,1.0,14/105,10.44%,SH3RF2;SMAD3;DLG1;CHCHD3;MTMR3;MAGI2;IKBKE;TP53;SH2D4A;DLG3;CDH5;MVP;ELL;GTF2F1
prerank,cytokine receptor binding (GO:0005126),0.3085103854237683,0.9429186289206297,0.5576102418207681,0.8979136568025564,1.0,4/83,2.00%,TGFBR3;SMAD3;IL13RA1;IL18
prerank,transforming growth factor beta binding (GO:0050431),-0.34127130329193983,-0.9419553245550476,0.5550122249388753,0.8684982584701805,1.0,7/23,7.29%,LTBP1;LTBP4;ENG;THBS1;ACVRL1;TGFB3;CD109
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.393109230126986,-0.9410328576163969,0.54375,0.8660195159913274,1.0,2/14,2.84%,SLC26A7;SLC26A2
prerank,protein kinase C activity (GO:0004697),0.42449161289657966,0.9407798678248666,0.525830258302583,0.8994382982745742,1.0,5/14,12.99%,PRKCZ;SMG1;PRKCB;PRKCA;PRKCI
prerank,GTPase activity (GO:0003924),-0.23514594345867848,-0.9404175615092802,0.6509433962264151,0.8629617682494781,1.0,51/192,19.69%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;RAB31;KRAS;RAB3C;RAP1B;RAP1A;SRPRA;GCH1;RASL12;RAB27A;RHOB;GNAI1;DNM1;RERG;ARHGDIB;EEF1A1;RALB;GNA12;RAP2A;RHOH;GBP4;RAB18;ARL1;GNA14;RAB27B;GNB2;ATL2;HBS1L;MTG2;RAB38;GNAO1;GNAL;GNB1;RAB6A;RAB32;RRAS;SEPTIN9;TPPP;ARL8B;RHOBTB3;ATL3;RHEB;RAN;EEF2;MMAA;GPN3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3789890723950956,0.939983516374227,0.5484429065743944,0.8977623974976339,1.0,4/25,5.34%,MICAL3;CYP27A1;CYP26B1;POR
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3211262845094633,-0.9390977639904953,0.5439429928741093,0.8617419114533301,1.0,9/27,19.16%,SYT1;APOE;HSPG2;RELN;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,GTPase binding (GO:0051020),0.275214602385098,0.9373649355625119,0.5990279465370595,0.9001725219749138,1.0,59/195,19.16%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;NOX1;RAB34;BRAF;RIN3;EXOC2;TRIOBP;AMBRA1;RABGGTA;DNM1L;DOCK7;CYRIB;BECN1;RNF41;FGD1;MTSS2;OCRL;PDE6D;RALBP1;MYO1C;MAPKAP1;RGP1;ANKRD27;RAP1GAP;GOLGA4;SGSM2;RADIL;RUSC2;MICALL1;EXOC4;SPHK2;RAB29;ARFIP2;GOLGA5;TMEM127;KCTD13;SGSM3;OPTN;RRAGD;RABGEF1;PEX5;RANBP9;PAK2;TBC1D7;EVI5;RTKN;ARHGAP1;USP33;LAMTOR1;UNC13D
prerank,endopeptidase activator activity (GO:0061133),-0.42927662564199703,-0.9369377374115216,0.5731958762886598,0.8624005457830921,1.0,3/10,18.42%,VSIR;PSMD14;APH1A
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3563300879906598,0.9363200654783297,0.5456053067993366,0.8990175622846028,1.0,6/33,12.71%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.42955255991594765,-0.9351489875182888,0.5717344753747323,0.8620106377107891,1.0,2/10,9.64%,CD200;CD47
prerank,receptor tyrosine kinase binding (GO:0030971),0.32609431534196087,0.9339310449658068,0.5496987951807228,0.9009587043795845,1.0,12/56,12.33%,LRP4;PTPN14;ARHGEF16;FRS2;TP53;GAB2;CPNE3;NRG1;ALKAL2;FLT3LG;RNF41;PITPNM2
prerank,lipase activity (GO:0016298),0.3369087962141553,0.9314168679421376,0.5611285266457681,0.903240718443735,1.0,9/43,15.31%,CEL;LIPA;PLA1A;PNLIP;LYPLA1;DDHD2;ABHD12;SEC23IP;SMPD3
prerank,adenyl ribonucleotide binding (GO:0032559),0.266723655000364,0.9306129146315016,0.6211031175059952,0.901594592343373,1.0,52/291,16.24%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;MPPED2;SPHK1;PRKAG3;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;SLC19A1;NUAK2;CLPX;CDC42BPG;SIK1;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;ABCC6;BRSK1;CNBD2;SRPK2;ABL1;TRIB1;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;COQ8A;CAD;ATP5F1D;POPDC2;SYN3;STK17B;ACVR1B;STK4;CARS2;APRT;STK36;VPS4A;TLK2
prerank,methyl-CpG binding (GO:0008327),0.39033459265486065,0.9300870526203927,0.5474956822107081,0.8993134741240373,1.0,8/22,21.14%,CXXC5;CXXC4;ZBTB38;TET1;LRWD1;TET3;MBD1;MBD2
prerank,CoA hydrolase activity (GO:0016289),0.40537725195940844,0.9274960251331412,0.5406976744186046,0.901700406795415,1.0,4/16,17.08%,ACSBG2;ACOT11;ACOT8;ACOT12
prerank,SH3 domain binding (GO:0017124),0.31712445147839396,0.9259467576275354,0.5751824817518248,0.9017117914341495,1.0,9/62,7.94%,ADAM12;AFAP1;PRKN;SYNJ2;REPS1;AFAP1L2;PTPN22;PLSCR1;CNTNAP1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3413486937274907,0.9254381358226234,0.5516693163751988,0.8992742406569496,1.0,11/42,17.75%,CCNA2;CCNA1;CCNT2;CCND3;CCNB2;KAT2B;CCNG1;CCNL1;CCNE1;CNPPD1;HEXIM2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.352765270003991,0.9235716191495552,0.5666104553119731,0.8999018268649932,1.0,7/33,13.46%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43;TBP
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.41708746348146364,0.9224318976970476,0.5612244897959183,0.8991266326567012,1.0,5/13,19.01%,DNASE1L1;DICER1;DNASE1L2;FEN1;SLX4
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4096026808869012,-0.9222303411522038,0.5616161616161616,0.8890058829050526,1.0,5/10,29.90%,EXD2;POLD1;TATDN1;MGME1;APEX1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.40310083688629955,0.920097987551554,0.5658362989323843,0.9009047664590877,1.0,4/18,7.33%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.45151622012150894,0.9193416224541109,0.5648854961832062,0.8993367039536844,1.0,3/10,15.39%,NAA80;NAA20;NAA16
prerank,aminopeptidase activity (GO:0004177),0.36426579616475097,0.9187906074628132,0.5430016863406408,0.8972474850611063,1.0,8/26,17.61%,CTSH;NAALADL1;METAP2;NPEPPS;MMP14;ERAP1;ANPEP;XPNPEP1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.36761473988266946,-0.9187112544851602,0.5639412997903563,0.8919260939806336,1.0,7/15,26.45%,COX4I1;COX6A1;CYB5A;COX5B;COX5A;NDUFA4L2;COX4I2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3303463778607204,-0.9184358345172007,0.5801354401805869,0.8877764713007736,1.0,8/22,19.16%,SYT1;APOE;HSPG2;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4057370121216683,0.9176517204361206,0.5620300751879699,0.8963802173830686,1.0,5/14,20.85%,TSEN2;RPP21;PRORP;POP7;POP1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.40371281956732485,-0.9174491899306187,0.5615866388308977,0.8855501389477339,1.0,2/11,2.45%,SGMS1;SGMS2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.392773556171937,-0.9160206803083792,0.5745967741935484,0.8841499630176539,1.0,6/11,19.38%,RYR2;RYR3;TRPM2;ITPR3;TRPA1;RASA3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.35628697784205854,-0.9157686962278561,0.5733333333333334,0.8800653390117671,1.0,3/18,8.96%,STXBP6;ANXA1;PDLIM1
prerank,magnesium ion binding (GO:0000287),0.2787960569226083,0.9138266536313869,0.6177658142664872,0.9012783166668105,1.0,26/135,15.73%,EYA2;OXSR1;SPHK1;CLYBL;LRRK2;ATP4A;NUAK2;CDC42BPG;SIK1;MOV10L1;OPA1;PLSCR1;SRR;IDH1;BRSK1;SRPK2;ABL1;TDG;PGM1;THTPA;CERK;TDP2;STK4;XXYLT1;NT5C3A;RP2
prerank,heme binding (GO:0020037),0.30221137314003266,0.9127772968418567,0.5696969696969697,0.9002255115943769,1.0,11/65,11.42%,CYP27A1;FLVCR2;PGRMC1;CYP21A2;CYP26B1;SLC48A1;HRG;CYP2R1;CYB561D2;NOX4;CYB5B
prerank,ribonuclease P activity (GO:0004526),0.41635911261800906,0.9125080225575573,0.5512104283054003,0.8973802893586255,1.0,4/11,20.85%,RPP21;PRORP;POP7;POP1
prerank,cytokine receptor activity (GO:0004896),-0.2494372334197372,-0.9100017226375986,0.65,0.8890467651971545,1.0,21/83,18.18%,GHR;IL1R1;OSMR;LIFR;IL1RAP;IL1RAPL2;F3;IL6ST;FZD4;IL17RD;IFNGR2;CD44;IL4R;CMKLR1;CNTFR;IL31RA;GFRA1;CX3CR1;GFRA2;CD74;CRLF1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21924155277812474,-0.9082614837483203,0.8274111675126904,0.8883466054068787,1.0,90/248,27.02%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;MYL6;RAB31;MYH9;KRAS;RAB3C;RAP1B;RAP1A;SRPRA;GCH1;RASL12;RAB27A;RHOB;GNAI1;DYNC1I1;DNM1;RERG;ARHGDIB;EEF1A1;RALB;MYO6;GNA12;ABCD2;RAP2A;RHOH;GBP4;RAB18;KIF26A;HSP90AA1;ARL1;GNA14;RAB27B;ATP2B1;GNB2;ATL2;HBS1L;MTG2;RAB38;GNAO1;CLU;GNAL;GNB1;RAB6A;RAB32;RRAS;DHX9;SEPTIN9;TPPP;KIF15;ARL8B;RHOBTB3;ATAD1;DNA2;ATL3;RHEB;RAN;EEF2;MMAA;GPN3;CFTR;MYO1E;RND2;RAC3;GNL2;GEM;GPN2;RAB14;KIF5A;RHOC;RUVBL2;KIF14;RND1;MMUT;SAR1B;EEF1A2;RNF112;RAB1B;RHOG;GNG3;ABCA3;RAB5B;RAP2C;GNG8;KIF1A;TDRD9
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.26908462300169933,0.907803328627561,0.6472868217054264,0.9037670092603006,1.0,24/173,12.35%,AEBP1;MXI1;PPARA;FOXP4;ZBTB20;KCNIP3;MITF;NACC2;FOXP2;OTP;BHLHE41;RORC;IRX1;ZBTB26;SOX13;ZFP90;ZNF219;PRDM5;ZBTB6;NFATC3;MNT;ZBTB1;ZNF148;DEAF1
prerank,serine-type peptidase activity (GO:0008236),0.292166296321416,0.904740350396099,0.6061026352288488,0.9072175361280335,1.0,7/96,6.06%,CORIN;KLK2;F11;DPP4;CTSH;F2;TPP1
prerank,signal sequence binding (GO:0005048),-0.30186226567936136,-0.9042144753295389,0.6055276381909548,0.8928593583285774,1.0,11/35,21.77%,PEX5L;CEMIP;NFKBIA;KDELR3;AP2B1;CABP1;AP2M1;CAT;RANBP6;TOMM20;POM121
prerank,tubulin binding (GO:0015631),-0.21092208647068122,-0.9038066802190644,0.8466257668711656,0.8892051046445446,1.0,70/296,17.70%,DNM3;MTUS1;SGIP1;UNC5C;MAP1B;SYBU;AGBL4;STARD9;NAV3;TTLL7;REEP1;MID1;CLASP2;KIF21A;DST;MID2;CCDC88A;ARHGEF7;ARHGEF2;PAK1;RPS3;STMN2;DCX;DIP2B;DYNC1I1;KIF5C;DNM1;KIF26B;MTCL1;TUBGCP2;MAP6;FGF13;TRPV4;RP1;PACRG;CDK5RAP2;KIF26A;CLIP2;EML5;SETD2;SPEF1;MAP4;TRIM36;MAPT;RAB11FIP5;CLIP1;SNCA;KIF3A;CETN3;CDK5R1;GAS2L3;CCDC88C;ATF5;TERF1;STMN1;ALDOA;TTLL5;MAP1LC3A;KIF21B;MAP7D3;TPPP;GABARAPL2;APC;NUSAP1;CENPE;KIF15;ARL8B;EMD;FAM161A;CAPN6
prerank,cysteine-type peptidase activity (GO:0008234),-0.25570138238057055,-0.9034537062680623,0.6908517350157729,0.8854555040331813,1.0,25/73,21.03%,USP29;OTUD7B;CTSC;USP13;CTSB;PDIA3;CAPN2;UCHL1;CTSL;CTSS;CASP6;ATG4A;USP50;USP46;CTSO;USP14;USP8;CASP2;USP2;CTSZ;OTULINL;CASP4;ATG4B;USP42;SFRP1
prerank,guanyl ribonucleotide binding (GO:0032561),-0.222652004093831,-0.9031995799226941,0.7761904761904762,0.8814389666477704,1.0,50/196,19.52%,RHOBTB1;RHOJ;PDE10A;PDE11A;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;GCH1;RASL12;RAB27A;RHOB;GNAI1;RERG;EEF1A1;RALB;TUBA1A;MFHAS1;GLUD1;PDE2A;RAP2A;RHOH;GBP4;RAB18;TUBB4A;ARL5A;ARL1;RAB27B;ARL5B;ATL2;MTG2;RAB38;RAB6A;RAB32;TUBB2B;RRAS;ARF5;ARF6;RAB39A;ARL8B;RHOBTB3;TUBB3;ATL3;RHEB;RAN;TUBA4A;MMAA;PIP4K2B
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.43869574610848916,0.9028549969499133,0.5828571428571429,0.9078608092809094,1.0,3/11,15.39%,NAA80;NAA20;NAA16
prerank,phosphatase activator activity (GO:0019211),-0.37277006741192525,-0.902119121097997,0.5991561181434599,0.8793725177225056,1.0,5/14,10.44%,PPP2R5A;CALM1;CALM2;BMP2;CALM3
prerank,solute:sodium symporter activity (GO:0015370),-0.30264391085460113,-0.900259414244398,0.6067146282973621,0.8790299695300478,1.0,2/27,5.45%,SLC4A10;SLC5A6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.35795157780977743,0.8998430707863321,0.6038062283737025,0.9110713614708063,1.0,2/27,1.99%,SLC41A1;SLC8A3
prerank,lysophospholipase activity (GO:0004622),-0.3392715987403281,-0.8998414706607741,0.6160520607375272,0.8754977381066062,1.0,5/20,14.40%,PLA2G4A;MGLL;GDPD1;ENPP2;ABHD4
prerank,syntaxin-1 binding (GO:0017075),-0.3362820511469816,-0.8994272680528185,0.611764705882353,0.8721356715340179,1.0,7/22,12.22%,SYT1;SNAP25;UNC13B;SYPL1;NSF;SYNPR;DAPK1
prerank,adenylate cyclase binding (GO:0008179),0.42839590496856095,0.898259762878759,0.584870848708487,0.9111030229220074,1.0,2/10,3.91%,ADCY5;AKAP12
prerank,solute:proton symporter activity (GO:0015295),-0.3557759917536293,-0.8977046873336878,0.5766738660907127,0.8715565370586338,1.0,1/16,1.50%,SLC2A13
prerank,potassium ion antiporter activity (GO:0022821),0.4049200662506475,0.8965248685974123,0.5931558935361216,0.911512302729565,1.0,1/15,0.61%,SLC24A3
prerank,ATPase regulator activity (GO:0060590),0.33354910841377605,0.896431678435493,0.5973597359735974,0.9083402614998413,1.0,2/38,2.20%,ATP1B3;FNIP1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3198252455632935,-0.8947705121365959,0.6085858585858586,0.8737089224481301,1.0,5/24,7.78%,RPL41;RPL26;SYNCRIP;RPL5;RPS7
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4156402346402386,0.8929368144576175,0.5988483685220729,0.9121471557510688,1.0,6/12,23.73%,TENT2;TENT4B;PAPOLG;TENT5C;TUT1;TENT5D
prerank,neurexin family protein binding (GO:0042043),0.4359627801832622,0.8925743591565117,0.5952380952380952,0.9096126063220039,1.0,3/10,3.73%,SYTL3;NLGN2;CEL
prerank,steroid hydroxylase activity (GO:0008395),0.3788077202569088,0.88926715281658,0.5963636363636363,0.9133586108004862,1.0,3/16,8.77%,CYP27A1;CYP21A2;CYP2R1
prerank,protein phosphatase 2A binding (GO:0051721),-0.3217913602302502,-0.8892535103753831,0.6241758241758242,0.881598643475176,1.0,7/23,13.82%,GRIN3A;DAB2IP;FOXO1;MFHAS1;MAPT;SMG5;STRN4
prerank,CARD domain binding (GO:0050700),-0.35828889684876913,-0.8890359525549175,0.6252676659528907,0.8777740605392695,1.0,6/14,19.14%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4
prerank,O-methyltransferase activity (GO:0008171),0.42279612982142356,0.8882960952323482,0.5686653771760155,0.9122249270512683,1.0,3/10,13.32%,LRTOMT;ASMT;CMTR2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3118633833441909,0.8869117863342724,0.631083202511774,0.9118496159141878,1.0,7/49,8.36%,SYT9;SYT11;SYT12;FER1L5;CPNE3;ANXA5;ANXA9
prerank,estrogen receptor binding (GO:0030331),0.3397876763345471,0.8866158001437582,0.6196721311475409,0.9092055450158095,1.0,4/32,7.18%,PPARGC1B;NSD1;LCOR;WIPI1
prerank,poly-purine tract binding (GO:0070717),0.35104349302558113,0.8836383306231366,0.6083333333333333,0.912172726246699,1.0,10/27,18.46%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;PABPC5;HNRNPDL;DAZAP1;RBMS3;LARP4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.36752299702034696,0.8823281941654668,0.6125,0.9117056801446296,1.0,8/22,19.96%,PARP10;IKBKE;TAB2;ZBTB1;UIMC1;OPTN;SQSTM1;WDR81
prerank,nuclear import signal receptor activity (GO:0061608),0.389520410604427,0.8821479778543794,0.6197440585009141,0.908920161385242,1.0,7/15,28.29%,TNPO1;KPNA6;TNPO2;HIKESHI;KPNA4;IPO4;KPNA1
prerank,ATPase activator activity (GO:0001671),0.36802894349802495,0.881578366309072,0.6039426523297491,0.906866614313074,1.0,1/20,0.71%,ATP1B3
prerank,protein tyrosine kinase binding (GO:1990782),0.2956256075771842,0.8811854971777033,0.6564774381368268,0.9045216644038341,1.0,15/71,12.33%,LRP4;PTPN14;EPHA4;ARHGEF16;TP53;CPNE3;NRG1;CDH5;ALKAL2;FLT3LG;NOX4;CASS4;RNF41;PTPN11;PITPNM2
prerank,tau-protein kinase activity (GO:0050321),0.3685188983978857,0.8794976923105801,0.6283662477558348,0.9048477800914853,1.0,3/20,10.70%,ROCK2;BRSK1;DYRK1A
prerank,exopeptidase activity (GO:0008238),0.31080480169767377,0.8789071764955668,0.6264090177133655,0.9028925864060605,1.0,14/50,17.61%,ACE;DPP4;CTSH;NAALADL1;DPP8;METAP2;RCE1;NPEPPS;FOLH1;ERAP1;ZMPSTE24;ANPEP;DPP7;XPNPEP1
prerank,Wnt-activated receptor activity (GO:0042813),-0.3530184250987601,-0.8775109518156077,0.6213389121338913,0.8991310973162249,1.0,4/15,10.70%,ROR1;FZD4;TSPAN12;PKD1
prerank,myosin V binding (GO:0031489),-0.35005285593918417,-0.8771486266700637,0.6179540709812108,0.8955294336943767,1.0,9/15,38.60%,RAB3C;RAB27B;RAB6A;RAB14;RAB3A;RAB3B;RAB6B;RAB25;RAB11A
prerank,miRNA binding (GO:0035198),0.33929210665165,0.8754189443469123,0.631404958677686,0.9068496756585849,1.0,13/30,26.19%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;RBM4;TUT7;ZC3H10;FMR1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,endopeptidase activity (GO:0004175),0.2494655657682811,0.8737703030521397,0.766109785202864,0.9073064979397274,1.0,52/257,19.77%,ACE;CORIN;ADAMTS10;BACE2;KLK2;F11;TRABD2B;ADAMTS2;ADAMTS15;CASP3;ADAMTSL5;DPP4;CTSH;F2;ADAMTS9;USP9X;USP24;TPP1;USP11;MMP19;RCE1;ADAM28;USP34;MMP14;ADAM17;USP49;USP12;USP7;MBTPS1;PCSK7;USP18;PITRM1;PREP;ADAMTS7;ZMPSTE24;NRDC;PLAT;CELA3A;USP37;TYSND1;PIDD1;PRSS36;USP48;USP1;ADAMTSL4;CLPP;USP33;PCSK4;USP16;USP35;AFG3L2;ECEL1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.3285134671554292,-0.8729220075053844,0.672645739910314,0.9000475306811389,1.0,6/21,18.07%,AKAP6;RYR2;KCNQ1;WASF1;WASF2;ACBD3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.27923157076559324,-0.8695149227953193,0.648876404494382,0.9033280602116417,1.0,9/38,15.98%,HIP1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;SESTD1;PHLDA3;ZFYVE28;SNX27
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.2818883768235979,-0.8649758125019168,0.7153652392947103,0.9082805733012923,1.0,16/38,20.50%,PIK3R1;SHANK3;GRIP1;NCK2;G3BP2;SHANK2;SH2B2;AXIN1;SHANK1;NCK1;BLNK;LDLRAP1;SPATA2;IRS1;SHC1;SPAG9
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.42233035006614816,0.8649464291345774,0.6297071129707112,0.922094835840526,1.0,4/10,18.15%,NSD1;NSD3;ASH1L;SETD3
prerank,anion:anion antiporter activity (GO:0015301),-0.34682628825195727,-0.8628041948557051,0.6344086021505376,0.9082847742982858,1.0,2/17,2.84%,SLC26A7;SLC26A2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.23803147855919277,0.8606938817731896,0.8185890257558791,0.9273052192473302,1.0,70/431,16.24%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;RHOQ;RHOBTB2;RHOD;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;LRRK2;MYO18A;GNAT2;P2RX3;ATL1;GBP3;NUAK2;CLPX;CDC42BPG;SIK1;GBP7;MOV10L1;GCK;GBP2;SRR;RRAS2;GTPBP4;PPIP5K2;ARL4A;RAB11B;MKNK1;ABCC6;BRSK1;RAB13;SRPK2;ABL1;RAB22A;RABL6;TRIB1;CDC42;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;DNM2;TUBB2A;CAD;GBP6;ATP5F1D;SYN3;REM1;STK17B;RAB29;ACVR1B;STK4;RAB21;CARS2;ARFIP2;ARL6;STK36;VPS4A;TLK2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3013469230278003,0.8510102347277356,0.6777777777777778,0.9434783997539214,1.0,11/49,17.88%,PARP10;ZFAND6;BABAM2;IKBKE;TAB2;ZBTB1;UIMC1;DZIP3;UFD1;OPTN;SQSTM1
prerank,nuclease activity (GO:0004518),0.30145444549248834,0.8499494524536051,0.6895475819032761,0.9423855809391181,1.0,16/52,24.85%,DNASE1L1;PLSCR1;SAMHD1;SND1;REXO5;PNKP;DFFB;DIS3;DNASE1L2;OGG1;FEN1;RNASE12;MAP1S;REXO4;N4BP2;REXO1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.35931975150316003,0.8473514983068937,0.6466431095406361,0.9444859947820256,1.0,4/20,12.64%,SENP3;USP9X;DESI2;USP7
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.34790577172706305,-0.8471315907766387,0.6813417190775681,0.9364153790346689,1.0,5/14,11.53%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,endonuclease activity (GO:0004519),0.30328427352989845,0.842808459011355,0.6885758998435054,0.9501785423808422,1.0,16/49,24.43%,ZC3H12B;SND1;DICER1;PNKP;ZC3H12C;DIS3;NYNRIN;CPSF3;MBD4;OGG1;FEN1;AGO1;REXO4;SMG6;N4BP2;LACTB2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.32063420838044016,-0.8421835134158361,0.6915887850467289,0.9417851049995702,1.0,12/19,30.71%,WRNIP1;DHX9;DNA2;RFC4;RFC2;POLQ;MCM6;RFC5;HELB;CHTF18;RAD51;PIF1
prerank,nuclear export signal receptor activity (GO:0005049),-0.38289497471133466,-0.8397862508073298,0.6834381551362684,0.9422304704270179,1.0,4/11,21.24%,XPO1;EIF4ENIF1;RAN;XPO6
prerank,protease binding (GO:0002020),0.2713142405853746,0.8358509685733105,0.7510489510489511,0.9605843883931307,1.0,17/99,9.72%,TIMP3;PRKN;CFLAR;DPP4;BDKRB2;POLG;CD28;LCOR;TP53;SERPINE1;COMP;PTEN;COL1A2;TWNK;ANXA9;RIPK2;STIM1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.38242123793309446,0.8348938494226675,0.6640316205533597,0.959111535997414,1.0,3/12,11.59%,PAN3;PNLDC1;NOCT
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.334253564946687,0.8345843401882865,0.6795302013422819,0.9565189990460171,1.0,6/27,12.35%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,palmitoyltransferase activity (GO:0016409),-0.2912807017702643,-0.8333754164155975,0.7093023255813954,0.950239121968688,1.0,5/28,12.48%,ZDHHC9;HHAT;ZDHHC2;GOLGA7;ZDHHC14
prerank,retinoid X receptor binding (GO:0046965),0.3930686712832846,0.8328296613813895,0.6431372549019608,0.9565102361742559,1.0,3/11,11.13%,NSD1;HMGA1;RARG
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.40274483623888524,0.8303914750996316,0.6654275092936803,0.958017609379861,1.0,1/11,1.34%,KCND3
prerank,single-stranded DNA binding (GO:0003697),0.2669976456173215,0.8274417648757094,0.7700831024930748,0.960583391017482,1.0,25/93,21.23%,SSBP2;PCBP2;POLR2D;SAMHD1;FBH1;TWNK;SSBP1;RBMS1;RTF1;RBBP8;MSH3;IGHMBP2;TOP3A;MCM7;MCM2;PURB;TDP2;FUBP3;RAD51D;APTX;POU4F1;MCM9;POLR2G;MLH1;MCM5
prerank,peptidase activator activity (GO:0016504),-0.30409216227750013,-0.8248642205072259,0.7413394919168591,0.962328570961459,1.0,7/22,19.65%,CAV1;MAL;VSIR;PSMD14;PINK1;APH1A;PCOLCE
prerank,Hsp70 protein binding (GO:0030544),0.32017434100609576,0.8219302864568988,0.7135678391959799,0.9676205929881726,1.0,3/31,3.01%,PRKN;PPEF2;HDAC8
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2966337760295652,-0.8214751122622048,0.7447795823665894,0.9639786190313241,1.0,4/22,9.27%,ATP6V0A1;ATP2C1;ATP6V0A4;ATP2A3
prerank,calcium channel inhibitor activity (GO:0019855),-0.3536572391191285,-0.8206877310733767,0.7016806722689075,0.9608712953543107,1.0,5/11,12.96%,CALM1;CALM2;FKBP1A;SLC30A1;MCUB
prerank,growth factor activity (GO:0008083),0.27379498299517324,0.8203719695430616,0.7602427921092565,0.9672976873888125,1.0,16/74,18.90%,FGF1;F2;IL12B;OSGIN2;GDNF;NRG1;HBEGF;OSGIN1;VEGFD;TGFA;INHA;AMELX;NRTN;ARTN;VEGFB;BTC
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.32704671976934563,-0.819729837367441,0.6997840172786177,0.9582865892682907,1.0,6/18,14.18%,GAS6;RPS6KA3;SERPINB9;SNCA;RPS6KA1;MT3
prerank,microtubule plus-end binding (GO:0051010),-0.3054668329801252,-0.8196020604745354,0.7097505668934241,0.9541229768924622,1.0,6/20,16.95%,CLASP2;DST;CLIP4;CLIP2;CLIP1;APC
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3420317654705108,-0.8174428960005623,0.7052631578947368,0.9537363757813776,1.0,4/13,30.18%,SREBF2;IDI1;EBP;DDT
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3909600350316643,0.8164438285245075,0.6719367588932806,0.9714325279614416,1.0,3/11,22.06%,PADI6;PADI4;ARG1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3238386405013489,-0.8154877800324388,0.7359307359307359,0.9531457599743747,1.0,5/16,11.53%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,chemoattractant activity (GO:0042056),-0.29002728033021286,-0.8153289730395077,0.7657657657657657,0.9491786972713588,1.0,6/26,15.04%,VEGFC;FGF2;BMP4;FGF7;VEGFA;SCG2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.23205166674754407,0.8126676804811396,0.8855421686746988,0.9750147732689836,1.0,33/269,11.88%,SMAD3;SNCAIP;PPARGC1A;SYT11;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;SMAD6;IKBKE;FZD5;ARRB1;STAT2;TRIB2;TP53;TRIOBP;PTPN22;RNF8;AMBRA1;CDK5RAP3;RNF34;DNM1L;PARP9;RIPK1;BECN1;TRIB1;MAGEC2;GLMN;AXIN2;CUL4A
prerank,galactosyltransferase activity (GO:0008378),0.38615963432133155,0.810031228751282,0.6975425330812854,0.9767565483132415,1.0,4/11,13.27%,B4GALT1;A3GALT2;A4GALT;B4GALT2
prerank,glucuronosyltransferase activity (GO:0015020),-0.30982446012896087,-0.8098343063226171,0.7695652173913043,0.9542695719217393,1.0,3/19,9.43%,CSGALNACT1;EXT1;EXT2
prerank,microtubule binding (GO:0008017),0.23360197025058985,0.8091761542932654,0.8647281921618205,0.9751843677644559,1.0,22/222,9.72%,FMN1;GJB6;MTUS2;EML4;KIF13B;HOOK2;KIF2A;EML2;CLASP1;LRRK2;EZR;CCDC69;MAP2;KIF3C;APC2;OPA1;KIF1B;FBXW11;CEP57L1;DNM1L;KIF1C;STIM1
prerank,regulatory RNA binding (GO:0061980),0.295587958944541,0.8084013702519898,0.7427652733118971,0.9734044173590267,1.0,14/38,26.19%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;DICER1;RBM4;TUT7;ZC3H10;FMR1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,growth factor receptor binding (GO:0070851),0.2558194536261116,0.8083815664983236,0.7712691771269177,0.970293584968952,1.0,17/95,13.88%,FGF1;KL;FRS2;PDGFRB;IL12B;PLSCR1;ATXN2;HBEGF;FER;TRIP6;KLB;ADAM17;GLMN;VEGFD;TGFA;ERAP1;TLR5
prerank,motor activity (GO:0003774),-0.2378129449002181,-0.8078583872186047,0.8453038674033149,0.9534219126632628,1.0,24/60,26.91%,STARD9;KIF21A;MYL6;MYH9;DYNC1I1;KIF5C;KIF26B;MYO6;KIF26A;KIF3A;KIF21B;CENPE;DNAH3;KIF15;KIF11;MYO1E;KIF5A;KIF22;KIF4A;KIF3B;KIF14;KIF23;KIF1A;KIF17
prerank,receptor antagonist activity (GO:0048019),0.34759456096528646,0.8058024571798931,0.7114093959731543,0.9719473383562646,1.0,1/17,2.82%,DKK3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3182924033739104,0.803921650211307,0.7236614853195165,0.9721375293028514,1.0,4/28,9.72%,BID;BABAM2;EDA;RIPK1
prerank,DNA polymerase activity (GO:0034061),0.330220204733776,0.8033838687935831,0.7045871559633028,0.9700046980271498,1.0,6/22,15.97%,POLM;POLG;REV1;TERT;POLE2;POLL
prerank,nucleosomal DNA binding (GO:0031492),0.32900288583594955,0.8026615526949368,0.7118353344768439,0.9681863573204278,1.0,11/21,24.40%,CHD4;SMARCA4;SMARCC2;SMARCE1;HDAC1;HNRNPC;MTA2;SMARCD2;MBD2;SMARCB1;H1-0
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3775061109841371,0.8023354132408592,0.6906614785992218,0.9656328765949131,1.0,1/11,1.08%,SRRM2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2891472453722575,-0.8019170574802168,0.7695961995249406,0.9593523024951525,1.0,7/24,14.65%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;PLEKHA3;SESTD1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3791951618785323,0.8010989310548464,0.7073643410852714,0.964736882822274,1.0,3/11,19.13%,UBR5;AMFR;UBE4B
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.266577095215338,0.7992376933648913,0.7743362831858407,0.9649690156343571,1.0,10/73,13.61%,LGR4;NPR1;NPR3;BDKRB2;MC2R;NMUR1;NLRP6;KISS1R;SORCS2;VIPR1
prerank,ubiquitin binding (GO:0043130),0.26258016946054125,0.7983964368785132,0.7815602836879433,0.9633537472482652,1.0,4/73,5.61%,SMAD3;PRKN;NEDD4;ASCC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.3835299258847142,0.7964274826269423,0.7139959432048681,0.9637400061134556,1.0,1/10,2.05%,LACC1
prerank,"DNA binding, bending (GO:0008301)",-0.3180411204857246,-0.7945191649673108,0.7767653758542141,0.967554706389971,1.0,5/14,16.80%,LEF1;TFAM;TERF1;HHEX;TOP2A
prerank,1-phosphatidylinositol binding (GO:0005545),-0.32918657280524255,-0.7923618606244572,0.740139211136891,0.9666595154647121,1.0,6/15,15.83%,EPB41;SCARB1;SNAP91;SESTD1;ZFYVE9;WDFY3
prerank,RNA binding (GO:0003723),0.21139491782502304,0.7920549075534783,0.9848484848484849,0.9680251006987157,1.0,242/1321,17.99%,NSA2;CPEB2;PPARGC1B;CELF2;ROCK2;TRMT9B;BICC1;SRRM2;DDX5;PPARGC1A;NUDT4;POLR2A;HOXB6;MSI2;SON;SNTB2;RBM47;TNRC6A;CPEB4;IFIT1;IFIT2;MRPS23;ZC3H7B;OAS2;RBMS2;TDRD3;NXF2;FNDC3B;TNPO1;LARP4B;SNRNP70;IFIT3;KNOP1;PCBP2;PABPN1;MYO18A;PRRC2B;MBNL2;TLR3;EZR;SMG1;HNRNPR;KYAT3;RBM28;METAP2;IGF2BP1;FAM120A;HNRNPH1;SRSF5;DDX3X;ERI3;TRIM56;SIDT2;CCDC86;ZC3H12B;ANKRD17;PNO1;POLDIP3;EIF2AK2;ANXA11;MOV10L1;LGALS1;ZCCHC13;TNS1;CLUH;CPNE3;ZC3H4;TIA1;SNIP1;HNRNPA2B1;SIDT1;GOT2;MEX3A;MRPL37;MRPL2;TUT4;POLR2D;HUWE1;TNRC6B;PABPC4L;SAMHD1;SAMD4A;PARP12;TEP1;ATXN2;RBM15;SPEN;RBM39;LARP1;CPEB3;EXOSC7;TERT;SLTM;IGF2BP2;ARHGEF1;JMJD6;DIAPH1;NOVA1;SND1;FLYWCH2;RBM27;ZC3H18;DQX1;CSDC2;SSBP1;C1D;LRP1;RBMS1;KIF1C;ZC3HAV1;DDX60;SCAF4;LARP7;GPKOW;GTPBP4;CCAR1;KHDC4;MOV10;NUP42;PPAN;LSM14A;PTRH1;TRIP6;CRKL;YTHDF3;TBRG4;LUC7L3;GTF2F1;SCAF8;RRP36;KMT2C;SURF6;THRAP3;SRPK2;LRRC47;RTF1;ZNF346;SAP18;NOM1;EIF4A2;NUP98;DDX18;NXF1;ANKHD1;PNLDC1;PRKDC;HNRNPL;DHX58;RPP21;MRPS7;NOCT;CWC15;SUGP2;DICER1;NELFCD;PHF5A;SRSF11;NOP2;IGHMBP2;DDX6;ETF1;DCP1A;SLC25A11;CLTC;NOC4L;ALDH6A1;WDR43;POLR1G;CAST;AKAP1;RBPMS2;GSPT2;LBR;DHX33;OAS3;PNISR;ZC3H12C;PSIP1;RAMAC;ILF2;HNRNPC;RSL1D1;SCAF11;UBAP2L;MRPS26;DZIP3;IMMT;PUS10;SEC23IP;FCF1;RBM34;PURB;ATP5F1C;NYNRIN;PABPC5;PRPF3;LGALS3;ANXA7;ZFP36L1;SARNP;TENT4B;VIRMA;FUBP3;SNRNP40;SEPSECS;RBM4;HNRNPDL;SLC4A1AP;DAZAP1;DUSP14;FARSA;HNRNPM;CPSF3;RPP25L;DIDO1;TUT7;NEMF;EXD1;FRG1;GRSF1;ALKBH5;MRPL1;POP7;ILF3;ATXN2L;ZCRB1;PCDHGA9;DUS3L;RBMS3;DYNC1LI1;CHD2;PRPF6;KDM1A;HEXIM2;DDX55;FAM120C;FUS;EXOSC3;SRSF1;RPUSD4;EIF4G1;PKN2
prerank,tRNA binding (GO:0000049),0.28910820062556886,0.7914457703386147,0.7784810126582279,0.9660208617518496,1.0,6/43,17.95%,TRMT9B;TERT;IGHMBP2;SEPSECS;NEMF;RPUSD4
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.34323950428437244,0.7897545500456767,0.7203703703703703,0.9658895409060302,1.0,4/17,13.56%,AK4;AK3;NME6;AK8
prerank,metalloendopeptidase activity (GO:0004222),0.25921222263210003,0.7894083490818731,0.8251121076233184,0.9634313106006924,1.0,14/76,15.36%,ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;ADAMTS9;MMP19;RCE1;MMP14;ADAM17;PITRM1;ADAMTS7;ZMPSTE24;NRDC
prerank,ubiquitin protein ligase binding (GO:0031625),0.2260384727240596,0.7892002728148968,0.8976857490864799,0.9607803988564969,1.0,30/254,11.88%,SMAD3;SNCAIP;PPARGC1A;SYT11;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;SMAD6;IKBKE;FZD5;ARRB1;TRIB2;TP53;TRIOBP;PTPN22;RNF8;AMBRA1;RNF34;DNM1L;RIPK1;BECN1;TRIB1;MAGEC2;GLMN;AXIN2;CUL4A
prerank,telomeric DNA binding (GO:0042162),0.3032243977150843,0.78838232841131,0.7529411764705882,0.9592313655876494,1.0,10/32,19.46%,SMG1;ACD;HNRNPA2B1;TERT;RAD50;ZBTB48;TELO2;KDM1A;TINF2;UPF2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3751428766163511,0.7858250656925817,0.7132216014897579,0.9602417174283179,1.0,1/11,3.07%,AKR1B10
prerank,SUMO binding (GO:0032183),0.3735560020090406,0.7857837542040372,0.7181467181467182,0.9573574540720674,1.0,13/13,62.67%,TDG;PML;USPL1;SIMC1;USP25;UBA2;CASP8AP2;HERC2;HABP4;RNF111;RNF4;CBX4;SERBP1
prerank,voltage-gated anion channel activity (GO:0008308),0.3489156922789399,0.785258631504123,0.7274436090225563,0.9553120611850687,1.0,3/15,7.30%,CLCN2;VDAC2;ANO6
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3017612983015709,0.7837391741200529,0.7635726795096323,0.9547242005932884,1.0,9/34,17.82%,ERI3;EXOSC7;ERI2;PAN3;PNLDC1;NOCT;DIS3;DIS3L;EXOSC3
prerank,solute:anion antiporter activity (GO:0140323),0.3593183363979904,0.7797941048872253,0.718336483931947,0.9583097645238596,1.0,3/14,7.85%,SLC7A11;SLC26A3;SLC26A1
prerank,pyrophosphatase activity (GO:0016462),0.27837523977057377,0.7796197125605911,0.7777777777777778,0.955769864611904,1.0,5/50,6.63%,NUDT4;CILP2;LHPP;DDX3X;ENPP3
prerank,mannosyltransferase activity (GO:0000030),-0.28568274960168083,-0.7794993481660067,0.7600896860986547,0.9841624594311069,1.0,2/21,5.73%,TMTC2;DPY19L1
prerank,deoxyribonuclease activity (GO:0004536),0.3458054568328494,0.7791188833614809,0.7263969171483622,0.9537205936486934,1.0,5/14,21.50%,DNASE1L1;DFFB;DNASE1L2;MBD4;MAP1S
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.26776726491171443,-0.7768320046140059,0.8369829683698297,0.9840163297502086,1.0,2/29,3.31%,ACER3;ACER2
prerank,voltage-gated chloride channel activity (GO:0005247),0.38033777750504083,0.7756233945494323,0.734251968503937,0.9566460072827263,1.0,2/10,7.30%,CLCN2;ANO6
prerank,carboxylic ester hydrolase activity (GO:0052689),0.250990867267218,0.774779490861154,0.8401759530791789,0.9551420645293922,1.0,11/85,10.53%,PAFAH2;CEL;LIPA;ASPG;PNLIP;LYPLA1;PON3;DDHD2;PLA2G6;PTRH1;ABHD12
prerank,snoRNA binding (GO:0030515),0.2979035973526009,0.7731958013057599,0.7609427609427609,0.9549462982159586,1.0,1/30,1.47%,NUDT4
prerank,neuropeptide receptor activity (GO:0008188),-0.2671496117684822,-0.7728613522516177,0.7985781990521327,0.98574384958428,1.0,2/29,3.35%,SORCS1;SORCS3
prerank,histone methyltransferase binding (GO:1990226),-0.3353873763257632,-0.771500118572125,0.7761506276150628,0.983525060873449,1.0,4/11,21.01%,HSP90AB1;CTNNB1;NOP56;LCORL
prerank,ephrin receptor binding (GO:0046875),0.32371626783105156,0.7624734968589352,0.7673179396092362,0.9687071687633265,1.0,1/21,0.55%,EFNB2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.33166689280212847,-0.7618489162421874,0.7834008097165992,0.9935151405586383,1.0,1/12,1.36%,SLC2A1
prerank,tau protein binding (GO:0048156),0.2809915820764078,0.759381939047394,0.8038897893030794,0.9705422706009127,1.0,3/40,5.20%,ROCK2;PICALM;MAP2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.36387638651699983,0.7571531852021113,0.7466666666666667,0.9711115595887218,1.0,3/10,10.43%,ATM;PIK3CA;PIK3R3
prerank,protein kinase inhibitor activity (GO:0004860),-0.24613145200675618,-0.7556333392723352,0.8582474226804123,0.9981698066874356,1.0,9/42,18.37%,CIT;YWHAB;INKA2;CDKN1A;SNCA;SPRED1;NCK1;MBIP;SPRY4
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3282950712711338,-0.7553669299229906,0.7830578512396694,0.9943756920162898,1.0,4/11,15.93%,TERF2IP;TERF1;STN1;RPA1
prerank,hexosaminidase activity (GO:0015929),-0.32019375581012244,-0.7528577552204924,0.7991803278688525,0.9935873576974293,1.0,2/12,8.51%,CEMIP;HEXB
prerank,3'-5' DNA helicase activity (GO:0043138),0.3309804965077637,0.7527713195196651,0.7967625899280576,0.9748412013970205,1.0,4/16,13.34%,FBH1;FANCM;MCM7;MCM2
prerank,neuropeptide receptor binding (GO:0071855),0.33394232176492883,0.7526469540799964,0.7818181818181819,0.9721691393160385,1.0,2/14,9.10%,APLN;AGRP
prerank,manganese ion binding (GO:0030145),0.2679103967699985,0.7505219600058228,0.8499210110584519,0.9723071332724241,1.0,10/48,18.69%,MPPED2;LARGE1;SOD2;B4GALT1;ABL1;LARGE2;TDP2;XXYLT1;XPNPEP1;FEN1
prerank,WW domain binding (GO:0050699),0.29292540391123734,0.7500336990205301,0.7677304964539007,0.9701430490480051,1.0,7/26,19.43%,PMEPA1;TCEAL8;TCEAL6;SCNN1A;PRRG4;NDFIP1;WBP1
prerank,death receptor binding (GO:0005123),0.3363660015553477,0.7499314766267929,0.7371323529411765,0.9674172102834518,1.0,3/15,9.72%,BID;EDA;RIPK1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3559866508544067,0.7497546308915236,0.7591836734693878,0.9620566409475255,1.0,3/10,18.07%,DUSP10;DUSP2;DUSP4
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3559866508544067,0.7497546308915236,0.7591836734693878,0.9620566409475255,1.0,3/10,18.07%,DUSP10;DUSP2;DUSP4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.24499609428239585,0.7486048412411628,0.8779411764705882,0.9609203979463006,1.0,25/78,22.45%,CFLAR;CASP3;CAPNS2;CTSH;USP9X;USP24;USP11;USP34;USP49;USP12;USP7;USP18;CAPN15;USP37;USP48;USP1;USP33;USP16;USP35;CASP12;GPAA1;CAPN8;USP5;CASP9;USP20
prerank,dynactin binding (GO:0034452),0.3466144560584061,0.7457699521749065,0.7647058823529411,0.9622731709487832,1.0,2/12,8.59%,SNX6;HTT
prerank,omega peptidase activity (GO:0008242),-0.20313170587008347,-0.7446974258924143,0.9438943894389439,1.0,1.0,19/89,17.73%,USP29;OTUD7A;ASRGL1;OTUD7B;USP13;PSMD14;UCHL3;UCHL1;USP31;YOD1;USP53;USP50;USP46;USP22;VCPIP1;APEH;USP14;USP8;USP2
prerank,ribonuclease P RNA binding (GO:0033204),0.3501254533173833,0.7434911456280078,0.770949720670391,0.9628498628382419,1.0,3/10,20.85%,RPP21;POP7;POP1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.24436998776814217,-0.7429094290037808,0.8850267379679144,0.9989363934696494,1.0,4/37,12.09%,LARS2;WARS2;GARS1;DARS2
prerank,phosphatidylglycerol binding (GO:1901611),0.3432049550974403,0.7412752280470211,0.7651515151515151,0.9632101229192747,1.0,2/13,7.05%,GSDME;OPA1
prerank,kinase inhibitor activity (GO:0019210),-0.24948963377936856,-0.7404193161148565,0.8651960784313726,0.9982267404029405,1.0,9/33,21.98%,YWHAB;RHOH;CDKN1A;SNCA;NCK1;MBIP;SPRY4;NPM1;LRP6
prerank,water transmembrane transporter activity (GO:0005372),-0.32098670168942545,-0.7402940087772667,0.8033826638477801,0.9941743005730617,1.0,2/11,7.57%,AQP4;AQP11
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2853323182034047,0.7399072898763871,0.8349358974358975,0.9622501380906148,1.0,6/33,12.35%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.33326999560482495,-0.7346165029673023,0.8309859154929577,0.9976350556206803,1.0,4/10,18.97%,B4GALT5;B3GALT1;B3GALT5;B3GALT6
prerank,deubiquitinase activity (GO:0101005),-0.2019272074429181,-0.7325926480963039,0.9621993127147767,0.9961249927627933,1.0,24/88,23.65%,USP29;OTUD7A;OTUD7B;USP13;PSMD14;EIF3F;UCHL3;UCHL1;USP31;YOD1;USP53;USP50;USP46;USP22;VCPIP1;USP14;USP8;USP2;COPS5;MINDY1;USP42;MYSM1;BAP1;JOSD2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.30258749189649764,0.7285427789987445,0.8186915887850468,0.9748179371357074,1.0,3/21,7.09%,POLM;POLG;REV1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.29270938202701746,-0.7270317080114004,0.826271186440678,0.999124739859528,1.0,2/14,10.97%,RDH10;ADH1A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.31045154004761955,-0.7253568828964994,0.8118609406952966,0.9969524780571652,1.0,5/12,20.08%,PIK3R1;SH2B2;BLNK;IRS1;SHC1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.27656691623678464,0.7251589162670867,0.8222222222222222,0.9765117897035966,1.0,8/33,17.82%,ERI3;EXOSC7;ERI2;PNLDC1;NOCT;DIS3;DIS3L;EXOSC3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2860044138193715,0.7233661661114204,0.8193979933110368,0.976086078442334,1.0,4/25,6.71%,FCHSD2;DAPP1;PLEKHA2;GAB2
prerank,NADP binding (GO:0050661),0.2706055527849521,0.7209918483190392,0.8431372549019608,0.9763357137027312,1.0,9/32,17.19%,GMDS;DPYD;NOX1;TM7SF2;MTRR;PGD;LBR;DECR1;CRYZ
prerank,proton transmembrane transporter activity (GO:0015078),-0.22815169424277376,-0.7188048926951356,0.9018567639257294,1.0,1.0,14/39,32.33%,COX4I1;COX6A1;CLCN3;CYB5A;UQCR11;COX5B;COX5A;ATP6V1F;NDUFA4L2;ATP6V1B2;COX4I2;UQCR10;CLCN4;SLC4A11
prerank,E-box binding (GO:0070888),-0.24255471199459297,-0.7184742975484598,0.9102564102564102,0.996818612075281,1.0,18/34,35.52%,HES1;SREBF2;ATOH8;TWIST1;TAL1;ZEB1;TFAP4;SNAI2;TCF3;BHLHE40;AHR;PRMT5;PER1;PPARG;ASCL1;GATA3;NEUROD2;CIART
prerank,RNA polymerase binding (GO:0070063),0.3100263398345205,0.7176819044294872,0.8181818181818182,0.9776627123394622,1.0,4/18,10.46%,NEDD4;PABPN1;CCNT2;SCAF8
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.33232628183447654,0.7158906102993626,0.8245931283905967,0.9770284193191718,1.0,2/11,17.53%,CHRNA5;CHRNB1
prerank,neuropeptide hormone activity (GO:0005184),0.29201190862631876,0.7144908706884392,0.8429319371727748,0.9761470954154614,1.0,4/22,17.49%,AGRP;SPX;NPFF;NMB
prerank,O-acyltransferase activity (GO:0008374),0.27357531449890654,0.7124314758988286,0.8366972477064221,0.9761270404885397,1.0,3/30,5.98%,MOGAT3;GPAT2;PIGW
prerank,DNA polymerase binding (GO:0070182),0.30247275704489057,0.7097850572961424,0.8123827392120075,0.976507478541815,1.0,3/18,7.97%,ACD;FANCI;SMARCA4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2739543395515952,0.7072433361747803,0.8747913188647746,0.9767238617437812,1.0,1/31,0.77%,UBE2E2
prerank,lysine N-methyltransferase activity (GO:0016278),0.2914568634735342,0.7065044237068836,0.8158844765342961,0.9748786218431952,1.0,5/20,18.15%,SETD7;KMT5A;EHMT2;EHMT1;SETD3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3151380297910742,-0.7057587397597682,0.8070866141732284,1.0,1.0,3/10,14.21%,ANKRD13A;LAPTM5;FAAP20
prerank,NF-kappaB binding (GO:0051059),-0.25326334454539756,-0.7055387341142806,0.8909512761020881,1.0,1.0,7/24,24.03%,NFKBIA;GSK3B;TAF4B;MTDH;NPM1;SETD6;RELA
prerank,phosphate ion binding (GO:0042301),-0.31527561855425423,-0.705132876609497,0.8438818565400844,0.9991775452473176,1.0,4/10,36.31%,PDE2A;RELA;RPH3A;MTHFD2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2691858202904783,0.7043906021581389,0.8341625207296849,0.9746234993490644,1.0,3/30,8.10%,SLC30A10;SLC30A2;SLC39A13
prerank,glucose transmembrane transporter activity (GO:0005355),-0.278759350961415,-0.7038530066855625,0.8628318584070797,0.9964132803876635,1.0,1/17,1.36%,SLC2A1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3174896111182309,0.702976973418598,0.8052434456928839,0.9735058493853582,1.0,3/14,13.56%,AK4;NME6;AK8
prerank,DNA secondary structure binding (GO:0000217),0.2692965227669397,0.7023103597283934,0.8625827814569537,0.9717067494725707,1.0,5/31,11.24%,KMT2A;HMGA1;FANCM;ABL1;RBBP8
prerank,3'-5' exonuclease activity (GO:0008408),0.25534836309788284,0.7019392008871665,0.8881469115191987,0.9694989234045857,1.0,11/45,17.82%,POLG;ERI3;EXOSC7;ERI2;PNLDC1;NOCT;RAD50;DIS3;EXD1;DIS3L;EXOSC3
prerank,phospholipase inhibitor activity (GO:0004859),0.33406885048970425,0.7014572422739914,0.8180039138943248,0.9673910441839508,1.0,4/10,21.31%,ANXA5;ANXA9;ANXA2;ANXA4
prerank,endoribonuclease activity (GO:0004521),0.27145013511780286,0.701012207871158,0.8492201039861352,0.9652782190254885,1.0,10/32,26.18%,ZC3H12B;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;AGO1;SMG6;LACTB2;AGO2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2542522648796076,0.700004267894761,0.8832236842105263,0.9639006959830779,1.0,17/40,28.43%,DNMT3A;HNMT;LRTOMT;TPMT;ASMT;SETD3;GNMT;METTL4;N6AMT1;METTL9;ICMT;PCMT1;PEMT;DNMT1;THUMPD3;FBLL1;AS3MT
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3060336918346014,0.6993687893885764,0.8180147058823529,0.9594374950798269,1.0,3/16,11.06%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3060336918346014,0.6993687893885764,0.8180147058823529,0.9594374950798269,1.0,3/16,11.06%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.28166248480347583,0.697676783532863,0.8518518518518519,0.9587397972421798,1.0,7/27,23.44%,POLR2A;POLR2D;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,adenyl nucleotide binding (GO:0030554),-0.30774546682722514,-0.6975509259278253,0.8583509513742071,0.9950879630778392,1.0,3/11,21.77%,HSPH1;BAG5;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.30774546682722514,-0.6975509259278253,0.8583509513742071,0.9950879630778392,1.0,3/11,21.77%,HSPH1;BAG5;BAG2
prerank,CCR chemokine receptor binding (GO:0048020),0.2703212628798398,0.6944761911784924,0.8657487091222031,0.9597102972676108,1.0,5/28,18.05%,DEFB1;CCL25;CCL15;CCR2;MSMP
prerank,gamma-tubulin binding (GO:0043015),-0.25083824188967896,-0.6915827124104535,0.8936651583710408,0.997201239952228,1.0,5/22,12.79%,ARHGEF7;PAK1;TUBGCP2;CDK5RAP2;RAB11FIP5
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.26172423472475975,0.686866260134412,0.8945634266886326,0.9654561332468128,1.0,1/34,0.77%,UBE2E2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.24809355028621932,-0.6852570604428369,0.8943661971830986,0.9994513508073966,1.0,4/24,12.48%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3253589293590652,0.6849989283284222,0.8327067669172933,0.9647801901968497,1.0,6/12,27.71%,LARP1;NCBP3;GEMIN5;CYFIP2;AGO2;EIF4E2
prerank,Hsp90 protein binding (GO:0051879),0.26092437639299604,0.6845329160750399,0.8758503401360545,0.9627113596955682,1.0,3/33,3.01%,PTGES3L;PPEF2;HDAC8
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2067490491888327,-0.6814594854363784,0.9663865546218487,0.9989767709448847,1.0,20/57,29.56%,COX4I1;COX6A1;CYB5A;NDUFB7;NDUFS6;UQCR11;COX5B;COX5A;NDUFA4L2;CYBRD1;NDUFS7;NDUFB8;NDUFB5;NDUFA6;NDUFA7;NDUFA13;COX4I2;NDUFA8;UQCR10;NDUFB10
prerank,protein phosphatase regulator activity (GO:0019888),0.24121719875018097,0.6813974025811361,0.9166666666666666,0.963324139421378,1.0,11/53,17.09%,PPP2R2B;PPP4R4;DMPK;EIF2AK2;PPP2R1B;PHACTR4;PPP2R5E;LGALS3;PPP4R2;SAG;PPP6R3
prerank,carboxy-lyase activity (GO:0016831),0.2721188564382445,0.6794891831265015,0.8761061946902655,0.9626885584544013,1.0,7/23,22.17%,AZIN1;MLYCD;ACOD1;ECHDC1;AZIN2;MVD;GGCX
prerank,death domain binding (GO:0070513),-0.28784920467294783,-0.6650546132439419,0.906832298136646,1.0,1.0,3/11,15.70%,DAPL1;DAP;CRADD
prerank,FMN binding (GO:0010181),-0.288372075948174,-0.664147349726161,0.8924949290060852,1.0,1.0,2/11,12.67%,NOS3;NOS1
prerank,microtubule motor activity (GO:0003777),0.22942605073893305,0.6608787442088198,0.9469453376205788,0.978178674368142,1.0,7/51,13.39%,KIF13B;KIF2A;KIF3C;KIF1B;KIF1C;KIFC1;KIF5B
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2833451166975218,0.65918489273035,0.8452173913043478,0.9771889991386552,1.0,1/16,2.38%,MACROD1
prerank,kinesin binding (GO:0019894),-0.23004968504837567,-0.6515293963283592,0.9406175771971497,1.0,1.0,9/27,28.83%,ACTB;SNCA;NEFH;NEK6;SPAG9;PRC1;CLSTN1;AP1AR;TTBK2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.29093978240931356,0.6504342344722144,0.8697247706422019,0.9821031933846547,1.0,5/16,19.67%,SLC22A5;SLC25A42;SLC25A17;SLC25A26;SLC22A4
prerank,mannose binding (GO:0005537),-0.28148156945235353,-0.6500110909680166,0.9,1.0,1.0,3/12,18.91%,LMAN2L;LMAN2;CLN5
prerank,methyltransferase activity (GO:0008168),0.234946027215098,0.6482940881728975,0.9364820846905537,0.9814830366552781,1.0,13/46,22.70%,LRTOMT;COQ5;ASMT;MGMT;METTL27;EHMT1;BUD23;NSUN4;METTL4;NDUFAF7;N6AMT1;AMT;EEF1AKMT1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2966997335442273,0.6450136108098045,0.8521897810218978,0.9816818268474415,1.0,3/12,10.43%,ATM;PIK3CA;PIK3R3
prerank,glutathione transferase activity (GO:0004364),0.26165509574153656,0.6392810595337989,0.8788927335640139,0.9838452697019264,1.0,2/23,10.03%,GSTT1;GSTA3
prerank,NADPH binding (GO:0070402),0.28710584264725414,0.638638705909709,0.860036832412523,0.981762190842103,1.0,5/13,19.28%,MTRR;LBR;DECR1;CRYZ;DUS2
prerank,antiporter activity (GO:0015297),0.26921704144170966,0.635612334313607,0.8824593128390597,0.9816140830797477,1.0,4/20,15.66%,TMEM241;SLC25A11;SLC35D1;SLC25A10
prerank,single-stranded RNA binding (GO:0003727),0.23232313358111295,0.632986183594978,0.9410801963993454,0.9810448909642285,1.0,15/43,26.18%,DDX3X;ZCCHC13;POLR2D;JMJD6;DDX60;DHX58;ILF3;SNRPC;POLR2G;FMR1;U2AF2;AGO1;LACTB2;AGO4;AGO2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2599379755975684,-0.6323987145313164,0.9327731092436975,1.0,1.0,4/14,17.70%,CAPN2;CAPN10;CAPNS1;CAPN6
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.2974577448685155,0.6322743787493281,0.8680688336520076,0.979112463549485,1.0,2/10,10.41%,NOX1;NOX4
prerank,DNA replication origin binding (GO:0003688),-0.2309756334137173,-0.6320115164771228,0.946067415730337,1.0,1.0,5/23,17.83%,POLA1;DHX9;ORC5;ORC2;CDC45
prerank,neuropeptide binding (GO:0042923),0.26735835786610707,0.6310755337317228,0.8914185639229422,0.9774697819390202,1.0,2/18,9.20%,SSTR3;NMUR1
prerank,thioesterase binding (GO:0031996),0.2953695752713219,0.6289334355452237,0.8703339882121808,0.9765564654512636,1.0,2/11,11.35%,ADRA2A;CDC42
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2579665527436855,-0.6273023201884204,0.9277899343544858,1.0,1.0,6/13,37.96%,METTL1;THUMPD2;TRMT11;TRMT10C;TRMT5;TRMT10A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.30006277463904596,0.6262343999457121,0.8807692307692307,0.9761117493781052,1.0,11/11,70.01%,FBXO11;NDUFAF7;PRMT2;PRMT7;PRMT6;PRMT9;CARM1;PRMT3;PRMT1;PRMT5;PRMT8
prerank,ribonuclease activity (GO:0004540),0.2183158350452789,0.6237212131079084,0.9666666666666667,0.9754687916247301,1.0,12/56,22.90%,ZC3H12B;SAMHD1;EXOSC7;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;EXOSC3;RNASE12;AGO1;SMG6
prerank,channel activity (GO:0015267),-0.1978906334997869,-0.622550655903285,0.9777777777777777,1.0,1.0,8/41,18.73%,AQP4;AQP11;TRPV4;MCUB;CHRNA7;TMEM266;PANX1;TRPA1
prerank,transferrin receptor binding (GO:1990459),-0.26770819590557804,-0.6020175604622793,0.9330543933054394,1.0,1.0,3/10,27.61%,IKBKB;CD81;SNX4
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2658653659410367,0.6014810390864094,0.9107468123861566,0.9877730225017204,1.0,3/14,12.64%,USP9X;DESI2;USP7
prerank,MHC protein binding (GO:0042287),-0.22913133597135857,-0.6011160629709812,0.9422632794457275,1.0,1.0,20/20,77.12%,TAP1;CD74;CD81;ATP5F1B;CD8B;COL2A1;KIR3DL2;TUBB;PILRA;FCRL6;ATP5F1A;CD4;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;LAG3;DERL1;ABCB9
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23148664338448002,-0.5998774492328424,0.9407582938388626,1.0,1.0,4/20,18.55%,RPS3;ERCC1;ENDOV;DNA2
prerank,sequence-specific mRNA binding (GO:1990825),-0.2736642544365758,-0.5977706208887427,0.9337474120082816,1.0,1.0,3/10,26.22%,SHFL;DHX9;RBM24
prerank,acetylcholine receptor activity (GO:0015464),0.24950251833551712,0.5955308400446855,0.9418803418803419,0.9888863401674187,1.0,5/22,17.53%,CHRNA5;CHRNG;ANXA9;CHRM1;CHRNB1
prerank,retinoic acid receptor binding (GO:0042974),-0.2305063928598905,-0.5930040595670798,0.9553571428571429,1.0,1.0,1/17,0.92%,ACTN4
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19193700126510982,0.5885568159082545,0.9871244635193133,0.9903562697157774,1.0,27/83,23.44%,USP3;USP9X;USP24;USP11;USP34;USP49;DESI2;USP12;USP7;USP18;USP37;UFD1;USP39;USP48;USP1;USP33;USP21;USP16;USP35;TANK;MPND;OTUD3;USP5;USP20;OTUD4;USP9Y;OTUB2
prerank,pseudouridine synthase activity (GO:0009982),-0.24446226356711676,-0.5881227900098135,0.9507494646680942,1.0,1.0,8/13,38.31%,PUS1;PUS7;TRUB1;DKC1;RPUSD3;RPUSD2;TRUB2;PUS7L
prerank,mRNA methyltransferase activity (GO:0008174),-0.25186214285708747,-0.5866077168522174,0.9525773195876288,1.0,1.0,2/12,15.42%,TRMT61B;METTL3
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.2418534946347347,-0.5841836787683926,0.9507186858316222,1.0,1.0,3/14,10.68%,NCF2;AIFM1;CYBA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.26317718658007283,-0.5826550049694474,0.9154334038054969,0.9995524419484122,1.0,5/10,39.11%,DPYSL5;OPLAH;DPEP1;DPYS;DPYSL2
prerank,RNA cap binding (GO:0000339),-0.23195333207435534,-0.5799836945025137,0.9608294930875576,0.9971019736995713,1.0,5/16,23.46%,EIF4E;EIF4A1;LSM1;EIF3D;NCBP2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.223871756687698,-0.5767305845185584,0.9647577092511013,0.9947279077880129,1.0,5/15,27.75%,P2RY12;P2RY1;GPR34;P2RY14;P2RX7
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2780794626344655,0.5732025609360127,0.9215686274509803,0.9959258878255018,1.0,6/10,31.35%,ATF2;EP300;MSL3;NAA50;NAA60;NAA40
prerank,metalloaminopeptidase activity (GO:0070006),-0.2300306656722152,-0.570198249681466,0.9665924276169265,0.9936109893927318,1.0,5/16,22.65%,ENPEP;MMP16;MMP15;TRHDE;RNPEPL1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23830076717816637,0.5629637363162351,0.9536541889483066,0.9983199279592223,1.0,2/18,12.67%,DHRS11;SRD5A2
prerank,snRNA binding (GO:0017069),0.20683350168279557,0.5586831922409407,0.9862595419847329,0.9978434246508702,1.0,12/42,25.95%,SNRNP70;CCNT2;LARP7;HEXIM2;EFTUD2;SNRPC;PRPF31;SNRPA1;TUT1;RNPC3;GEMIN5;SF3B3
prerank,exonuclease activity (GO:0004527),0.2010148772145581,0.5520368910028546,0.9828926905132193,0.9980865606410503,1.0,11/46,20.24%,POLG;ENPP3;EXOSC7;RAD50;REXO5;CPSF3;EXD1;EXOSC3;FEN1;DXO;RAD9A
prerank,MHC class I protein binding (GO:0042288),-0.2290306378704169,-0.5417090788286233,0.9704641350210971,0.9999280958234541,1.0,13/13,77.12%,TAP1;ATP5F1B;CD8B;TUBB;PILRA;ATP5F1A;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;DERL1;ABCB9
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.1771363157769051,-0.5385434180408483,0.987012987012987,0.997252042020162,1.0,13/35,29.52%,FOXP1;H3-3A;KLF10;TAF1B;ZBTB17;NPM1;RUVBL2;RELA;DR1;POU2F1;DRAP1;FOS;PARK7
prerank,telomerase RNA binding (GO:0070034),0.22089520526468276,0.5384775401851559,0.968141592920354,1.0,1.0,7/22,24.73%,TEP1;TERT;HNRNPC;TENT4B;SMG6;XRN1;PINX1
prerank,four-way junction DNA binding (GO:0000400),0.22628232518097618,0.5301208542787379,0.9620938628158845,1.0,1.0,5/17,21.99%,FANCM;ABL1;RAD51D;XRCC3;YY1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.24223983107647407,0.5219533149468712,0.9512670565302144,1.0,1.0,1/12,4.00%,BABAM2
prerank,5'-3' exonuclease activity (GO:0008409),-0.2073710317323056,-0.5198432824134508,0.9871244635193133,0.9984540247679689,1.0,3/14,21.06%,TRIR;XRN2;DCP2
prerank,damaged DNA binding (GO:0003684),0.19081941363076751,0.5196445126882375,0.996742671009772,0.9996270965461862,1.0,11/44,19.52%,RBBP8;PNKP;TDG;DDB2;SDE2;CREBBP;OGG1;NBN;FEN1;APTX;XPA
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.24224268908899446,0.5161735513228848,0.9678638941398866,0.9981193609357867,1.0,5/12,23.15%,HDAC1;TBP;TAF1;GTF2A1;TBPL1
prerank,nuclear localization sequence binding (GO:0008139),0.21129919677448683,0.492210879077739,0.9802513464991023,1.0,1.0,2/18,10.55%,TNPO1;KPNA6
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.22568899491493521,0.4854158060381031,0.9624060150375939,1.0,1.0,12/12,77.45%,CRYZ;CRYZL1;CBR4;NQO1;AIFM2;ADH4;AKR1C1;CBR1;DHRS4;NQO2;DCXR;NDUFS7
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2203942059071906,0.47979707661730236,0.9722772277227723,0.9995428965427609,1.0,4/12,21.98%,CISD3;ISCA1;SDHB;CISD2
prerank,U6 snRNA binding (GO:0017070),0.21498085012871232,0.4788636007467548,0.9859649122807017,0.9972697722695888,1.0,14/14,78.52%,LARP7;TUT1;LSM3;DDX39B;PRPF4;METTL16;SART3;EIF5A;PRPF8;LSM2;RBM22;LSM8;LSM7;LSM4
prerank,microtubule minus-end binding (GO:0051011),-0.200652938221999,-0.47328626303884114,0.9862700228832952,1.0,1.0,13/13,79.96%,TUBGCP2;HAUS4;TUBGCP6;CAMSAP3;CEP290;CAMSAP2;TUBGCP3;HAUS7;NUMA1;MACF1;TUBGCP5;CAMSAP1;TUBGCP4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.1643570913419938,-0.4668606949752897,0.9975308641975309,1.0,1.0,10/28,33.72%,ELAC1;DROSHA;RNASEH2A;ENDOV;POP4;APEX1;NUDT16;RPP30;AGO3;RNASEH1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.20058225148189052,-0.4532617843025206,0.9892703862660944,0.9985539816465328,1.0,5/10,38.66%,CDKN1A;CDKN2B;HEXIM1;CDKN2D;CDKN1B
prerank,exoribonuclease activity (GO:0004532),0.21200326448615708,0.4515656539314205,0.9766081871345029,0.9993930168125388,1.0,12/12,78.82%,EXOSC7;EXOSC3;EXOSC8;EXOSC9;CNOT6;EXOSC5;ZC3H12A;EXOSC2;EXOSC1;EXOSC4;EXOSC10;CNOT7
prerank,phosphatase inhibitor activity (GO:0019212),-0.17018724015190617,-0.44792077094598487,1.0,0.9955442438507375,1.0,2/20,8.73%,MGAT5;PTN
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.1667190545043064,0.4379176113423038,1.0,0.996368881285837,1.0,34/34,83.36%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.1667190545043064,0.4379176113423038,1.0,0.996368881285837,1.0,34/34,83.36%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.1351453141673467,0.27576963993477666,1.0,0.9999951087448306,1.0,10/10,86.49%,DESI2;OTUD4;STAMBP;STAMBPL1;ATXN3;OTUD5;USP27X;CYLD;TNFAIP3;YOD1
